On Narcotic Drugs, Psychotropic Substances, Precursors and Narcological Assistance

Machine translation. This text was translated from Georgian automatically and may contain inaccuracies. Only the Georgian text is legally binding: the original on legali.ge · the official publication on matsne.gov.ge. Translation of the consolidated version of 09.12.2025.

This document in other languages: ქართული (original) · Русский · Türkçe

Type of act

Law of Georgia

Number

№6245-Iს

Date adopted

22.05.2012

Text of the document

📑 Contents (40 articles)

Law of Georgia

On Narcotic Drugs, Psychotropic Substances, Precursors and Narcological Assistance

Chapter I. General Provisions

Article 1. Objectives of the Law, Scope of Regulation and Basic Principles🔗

1. The objective of this Law is the protection of the health of natural persons, ensuring state and public security and the fulfilment of the requirements provided for by the international treaties of Georgia.

2. This Law regulates relations related to the circulation of narcotic drugs, psychotropic substances and precursors on the territory of Georgia, establishes the legal foundations of state policy for the legal circulation of substances subject to special control and combating their illegal circulation and the principles of narcological assistance.

3. The basic principles of this Law are:

a) fulfilment of the requirements provided for by international treaties in the field of circulation of narcotic drugs, psychotropic substances and precursors;

b) promotion of ensuring the exercise of state control over the circulation of substances subject to special control;

c) determination of the competence of the state in certain types of activities related to the legal circulation of substances subject to special control;

d) priority of preventive measures aimed against offences related to the circulation of substances subject to special control and stimulation of the prevention of drug addiction;

e) ensuring adequate availability of narcotic drugs for medical purposes.

Article 2. Legislation of Georgia on Substances Subject to Special Control and Narcological Assistance🔗

The legislation of Georgia on substances subject to special control and narcological assistance is based on the Constitution of Georgia, the international treaties and agreements of Georgia and consists of this Law, other laws and normative acts subordinate to law developed on their basis.

Article 3. Definition of terms used in the Law🔗

For the purposes of this Law, the terms used therein have the following meaning:

a) narcotic drug – a substance of natural or synthetic origin, a plant or preparation containing this substance, which, on the basis of the relevant United Nations conventions, is included in Lists I and II of narcotic drugs subject to special control in Georgia;

b) psychotropic substance – a substance of natural or synthetic origin, a plant or preparation containing this substance, which, on the basis of the relevant United Nations conventions, is included in List III of psychotropic substances subject to special control in Georgia;

c) precursor – a substance of natural or synthetic origin which, on the basis of the relevant United Nations conventions, is included in Tables No. 1 and No. 2 of List IV of substances subject to special control in Georgia;

d) psychoactive substance − a substance of natural or synthetic origin which acts on the human central nervous system, causes a change in the person's mental state and is included in the Lists;

e) (deleted – 16 April 2014, No. 2235).

f) pharmaceutical product subject to special control − a medicinal product included in the Lists, permitted for medical use in Georgia under all trade names, as well as a pharmacologically active pharmaceutical substance obtained by natural or synthetic means;

f¹) medicinal product equated to a pharmaceutical product subject to special control – a pharmaceutical product which is not included in the list of substances subject to special control, but whose illegal circulation and abuse pose a serious threat to public health, aggravate the narcological situation in the country and which is included in the list defined by paragraph 4 of Article 5 of this Law;

g) substance subject to special control – all substances, pharmaceutical products, plant materials and mixtures obtained by natural or synthetic means which are included in Lists I, II, III and IV;

h) narcotic drug strictly restricted for circulation − an especially dangerous narcotic drug prohibited for medical use in Georgia, the use of which is permitted only for the purpose of carrying out educational, scientific-research and expert-diagnostic activities;

i) narcotic drug restricted for circulation − a narcotic drug permitted for medical use in Georgia;

j) List (Lists) – the list of substances subject to special control in Georgia, which is given in Annex No. 1 to this Law and is an integral part thereof;

k) dosage form of a substance subject to special control – a pharmaceutical product of any form in which only one pharmaceutical substance subject to special control is pharmacologically active;

l) preparation – a combined medicinal product in any physical state which, together with another pharmacologically active substance (substances), contains one or more pharmaceutical substances subject to special control;

m) pharmaceutical substance subject to special control (hereinafter – pharmaceutical substance) – a substance of any origin, of appropriate quality and pharmacologically active, which is included in the lists and is used for the manufacture of a dosage form and a preparation of a substance subject to special control and/or for the compounding of a medicinal product according to magistral and officinal prescriptions;

n) mixture – an unlawfully prepared blend in any physical state, of any type, form and content, which contains one or more substances subject to special control;

o) analogue of a narcotic drug – an unknown substance of natural or synthetic origin whose pharmacological effect on the central nervous system is similar to the pharmacological effect on the central nervous system of a narcotic drug defined by this Law;

p) special control – a set of measures applied by the State to prevent the unlawful circulation of substances subject to special control included in the lists;

q) circulation of substances subject to special control – sowing, growing, cultivating plants containing narcotic drugs and psychotropic substances, creation, production, preparation, manufacture-processing, storage, dispatch, transportation (carriage), sale (retail and wholesale), distribution, acquisition, unlawful transfer, unlawful sale, facilitation of unlawful sale, delivery, use, consumption, destruction, bringing in, taking out, import, export, transit, re-export of substances subject to special control;

r) legal circulation of substances subject to special control – circulation of plants and fungi containing a narcotic drug and a psychotropic substance and of substances subject to special control included in the lists, in compliance with the legislation of Georgia;

s) unlawful circulation of substances subject to special control – circulation of plants and fungi containing a narcotic drug and a psychotropic substance and of substances subject to special control included in the lists, in violation of the legislation of Georgia;

t) creation – development of an analogue of a narcotic drug;

u) production – serial manufacture of substances subject to special control, their dosage forms and preparations at a pharmaceutical enterprise holding the relevant permit, in accordance with the procedure established by the legislation of Georgia;

v) compounding of a pharmaceutical product subject to special control according to a magistral prescription – compounding of a pharmaceutical product subject to special control in a pharmacy for an individual patient;

w) Preparation of a pharmaceutical product subject to special control under an officinal prescription – preparation of a pharmaceutical product subject to special control in a pharmacy in accordance with the pharmacopoeia;

x) Manufacture and processing – all processes, except production and preparation, by means of which a substance subject to special control may be obtained, as well as the purification of a plant, substance or preparation from foreign impurities, the extraction therefrom of a substance subject to special control, and the change of the concentration of this substance;

y) Dispatch – movement (redirection) of a substance subject to special control within the territory of Georgia by any means, in the absence of the sender, the addressee and the authorised person of this substance;

z) Transportation (carriage) – movement of a substance subject to special control within the territory of Georgia by any means, by its manager or holder;

aa) Retail sale – issuance by an authorised person to a natural person of a pharmaceutical product subject to special control on the basis of an appropriate prescription, free of charge or at an established price;

bb) Wholesale sale – issuance by an authorised legal entity to a legal entity of a pharmaceutical product subject to special control on the basis of appropriate documentation, free of charge or at an established price;

cc) Unlawful transfer – transfer of a substance subject to special control in violation of the legislation of Georgia without the purpose of obtaining material benefit;

cc¹) Unlawful sale – transfer of a substance subject to special control in violation of the legislation of Georgia in exchange for receiving remuneration;

cc²) Facilitation of unlawful sale – creation of conditions for the unlawful sale of a substance subject to special control, in particular, packaging of this substance, placing it openly or covertly in a publicly accessible place, dissemination of information about its location, provision of information about the ways and methods of acquiring the said substance and/or any other act that facilitates the distribution of a substance subject to special control;

dd) Use – use of a pharmaceutical product subject to special control as prescribed by a physician;

ee) Unlawful use – use of a substance subject to special control included in the lists without a physician's prescription;

ff) Importation into and exportation from Georgia of a substance subject to special control – bringing a substance subject to special control from the territory of another state into the customs territory of Georgia or taking a substance subject to special control from the customs territory of Georgia to the territory of another state;

gg) Import, export, transit, re-export of a substance subject to special control, placing under the regime of storage of goods in a warehouse/terminal by declaration – import, export, transit, re-export, placing under the customs warehouse procedure as defined by the Tax Code of Georgia or the Customs Code of Georgia;

gg¹) Plants and fungi containing substances subject to special control:

H1 .a) Coca bush − any species of the genus Erythroxylon;

H1 .b) Opium poppy (sleeping poppy, khashkhash) − a plant of the species Papaver somniferum L.;

H1 .c) Hemp plant − any species of the genus Cannabis;

H1 .d) All species of cactus of the genus Loprophora;

H1 .e) All species of cactus of the genus Echinopsis;

H1 .f) Only the plant of the species Catha edulis of the genus Catha;

H1 .g) Ephedra plant − all species of the genus Ephedra;

H1 .h) Fungi of all genera of the family Strophariaceae;

gg²) Marijuana – the tops of the hemp plant with leaves, flowers and fruit (except seeds that are not accompanied by the tops of the plant), if no resin of any name has been extracted therefrom;

gg³) Cannabis resin – resin obtained (extracted) from the hemp plant, purified or unpurified;

gg⁴) Coca leaf – the leaf of the coca bush, except leaves from which ecgonine, cocaine and any other alkaloid of ecgonine have been completely removed;

gg⁵) Medicinal opium – processed opium used for medical purposes;

gg⁶) Opium – the coagulated milky juice of the poppy (Papaver somniferum);

gg⁷) Poppy straw – all parts of the harvested (reaped) opium poppy, except the seeds;

gg⁸) Sowing of the mycelium of a plant and fungus containing a substance subject to special control – the introduction of the seed of a plant containing a substance subject to special control into natural or artificial soil, or the planting of a seedling of the plant on any plot of land, including on uncultivated land, as well as in artificial and/or domestic conditions;

gg⁹) Growing of a plant and fungus containing a substance subject to special control – the tending of the sown and planted plant and fungus for the purpose of achieving the phase of their physiological maturity;

gg¹⁰) Cultivation of a plant and fungus containing a substance subject to special control – the selection of a plant and fungus containing a narcotic drug and psychotropic substance; an action aimed at obtaining a new species or hybrid of a plant or fungus which, or parts of which, contain a narcotic drug, psychotropic substance and/or precursor;

gg¹¹) Storage – any intentional act connected with the actual possession of a substance subject to special control in a building, hiding place or otherwise, if this act is not connected with its movement, regardless of the duration of storage;

gg¹²) Distribution – the transfer by an authorised person to a person of a specific quantity and type of a substance subject to special control allocated to that person;

gg¹³) Acquisition – the taking possession of a substance subject to special control;

gg¹⁴) Destruction – the neutralisation of a substance subject to special control;

gg¹⁵) Handover – the transfer of a substance subject to special control to an authorised body;

gg¹⁶) Reference standard samples of a narcotic drug, psychotropic substance and precursor – a high-purity standard metrological means in the form of a chemical substance, which is characterised by the properties and composition of a narcotic drug, psychotropic substance and precursor;

gg¹⁷) record-keeping – a unified system for recording the legal circulation of substances subject to special control;

gg¹⁸) internet pharmacy – a person operating online that sells a pharmaceutical product and/or, for the purpose of selling it, disseminates the relevant information;

gg¹⁹) institution providing narcological services – a medical institution that provides narcological and medical-psychological assistance to a user of substances subject to special control included in Lists I, II and III and to a person suffering from drug addiction;

gg²⁰) avoidance of the procedure required to establish the fact of the use of a narcotic drug and psychotropic substance – refusal of an authorised person's request for a clinical and/or laboratory examination;

gg²¹) quota for narcotic drugs, psychotropic substances and precursors – a limit determined taking into account Georgia's annual requirement for narcotic drugs, psychotropic substances and precursors subject to international control and submitted to the United Nations International Narcotics Control Board;

gg²²) drug addiction – a disease characterised by dependence on substances subject to special control included in Lists I and II;

gg²³) dependence on a psychoactive substance − a combination of physiological, behavioural and psychological phenomena that develops against the background of repeated use of a psychoactive substance and in which the desire to use that substance occupies first place in the individual's system of values, which is manifested by an irresistible need to use the psychoactive substance despite a clear awareness of the harmful consequence of use;

gg²⁴) person suffering from drug addiction – a person who has been diagnosed by the relevant medical institution with dependence on a substance subject to special control;

gg²⁵) unlawful user – a person who, without a doctor's prescription, uses a substance subject to special control included in List I, II or III, but has not developed a dependence on it;

gg²⁶) person with a somatic disease who is dependent on a psychoactive substance – a person suffering from a somatic illness who has been lawfully prescribed by a doctor a pharmaceutical product subject to special control and who has developed a dependence on it, as confirmed by the relevant medical institution;

gg²⁷) rehabilitation measures – a combination of medical and social measures aimed at the recovery and integration into society of a person dependent on substances subject to special control;

gg²⁸) warehouse stock – the quantity of pharmaceutical products subject to special control existing on the territory of the country, which is intended for export, for medical, scientific-research and expert purposes within the country, for the preparation of a pharmaceutical product subject to special control by magistral or officinal prescription, as well as for the production, permitted by this Law, of a medicinal product containing a pharmaceutical substance (substances) subject to special control;

gg²⁹) special warehouse stock – the quantity of pharmaceutical products at the disposal of the State, which is kept for special state purposes and emergency/special circumstances;

gg³⁰) Interagency Coordinating Council for Combating Drug Addiction – a coordinating body whose aim is to ensure effective and coordinated interagency cooperation directed against the illegal circulation of narcotic drugs, psychotropic substances and precursors in the country and towards the reduction of medical, social and economic harm caused by the use of narcotic drugs;

gg³¹) Competent National Authority of Georgia (Competent Authority) – the competent service subject to state control of the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia;

gg³²) domestic quota of the country – the limit determined for individual substances subject to special control and medicinal products equated thereto, which are not subject to international control, taking into account the annual demand of the country.

Law of Georgia of 5 March 2014 No. 2043 – website, 12.03.2014.

Law of Georgia of 16 April 2014 No. 2235 – website, 28.04.2014.

Law of Georgia of 5 July 2018 No. 3064 – website, 11.07.2018.

Law of Georgia of 28 June 2019 No. 4915 – website, 04.07.2019.

Law of Georgia of 16 April 2025 No. 505 – website, 17.04.2025.

Law of Georgia of 2 July 2025 No. 928 – website, 03.07.2025.

Article 4. Lists of substances subject to special control in Georgia and the introduction of amendments and additions thereto🔗

1. Substances subject to special control, according to the high potential for the development of dependence on them, their prevalence, duration of effect, social significance and danger to the health of the country's population, are included in Lists I, II, III and IV of substances subject to special control in Georgia:

a) List I − narcotic drugs strictly restricted for circulation − narcotic drugs with the highest medical and social risk, as well as other substances equated to them in terms of medical and social risk, the circulation of which is strictly restricted in the territory of Georgia;

b) List II − narcotic drugs restricted for circulation − narcotic drugs with high medical and social risk, permitted for use for medical purposes in the territory of Georgia, their dosage forms, as well as other substances equated to them in terms of medical and social risk, the circulation of which is restricted in the territory of Georgia;

c) List III − psychotropic substances − psychotropic substances with medium medical and social risk, permitted for use for medical purposes in the territory of Georgia, their dosage forms, as well as other substances equated to them in terms of medical and social risk;

d) List IV − precursors − substances (precursors) which are frequently used for the unlawful manufacture of narcotic drugs and psychotropic substances.

2. The lists of substances subject to special control in Georgia are given in Annex No. 1 to this Law and are an integral part thereof.

3. Substances subject to special control are included in the lists under their international non-proprietary (generic) name and/or chemical name and/or unregistered trivial name. The lists automatically include the dosage forms of the substances included therein, as well as of their salts, ethers, bases and isomers, where such exist, under any trade name, except for the exceptional cases provided for by this Law.

4. Taking into account the local narcological, epidemiological and criminogenic situation, in the case of appropriate justification, it is permissible to introduce amendments and additions to the lists, in particular, the transfer of any substance subject to special control from one list to another, its removal from a list or the addition of a new substance subject to special control to a list.

5. The grounds for introducing an amendment and/or addition to the lists are:

a) an official notification of the Secretary-General of the United Nations;

b) statistically confirmed information available to medical institutions, expert-forensic, judicial-investigative and/or law enforcement bodies on the facts of unlawful use entailing social danger of a specific substance subject to special control.

6. Changes and additions to the lists of substances subject to special control in Georgia shall be made by the Parliament of Georgia, taking into account the relevant recommendation of the Government of Georgia.

7. When determining the issue of assigning a plant, a substance subject to special control or a pharmaceutical product subject to special control to lists, only the lists and/or the explanations of the competent body shall be used as guidance.

Article 5. Regime of control of substances subject to special control🔗

1. A substance subject to special control included in List I shall be subject to a stricter control regime than a substance subject to special control included in List II.

2. A substance subject to special control included in List II shall be subject to a stricter control regime than a substance subject to special control included in List III.

3. A precursor included in Table No. 1 of List IV shall be subject to a stricter control regime than a precursor included in Table No. 2 of List IV.

4. The list of medicinal products equated with a pharmaceutical product subject to special control and the rules of legal circulation shall be determined by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia. The control regime and the rules of legal circulation established for the substances subject to special control included in the lists shall apply to the medicinal products included in the said list, including preparations.

5. It is prohibited to transfer a substance subject to international control to a list on which a less strict control is imposed than is provided for by international requirements.

Law of Georgia of 5 March 2014 No. 2043 – website, 12.03.2014.

Law of Georgia of 5 July 2018 No. 3064 – website, 11.07.2018.

Article 6. Small, large and especially large amounts of substances subject to special control and preparations containing them, withdrawn from illegal possession or circulation🔗

1. Small, large and especially large amounts of substances subject to special control included in Lists I, II and III, withdrawn from illegal possession or circulation, shall be determined by Annex No. 2 to this Law and constitute an integral part thereof.

2. The amount of the medicinal form (tablet, capsule, ampoule and others) of a substance subject to special control included in Lists I and II shall be determined in grams, recalculated to the pure substance, without its fillers (sugar, water, starch and others), and in the case of a preparation or mixture – without the substance that is not subject to special control.

3. If a preparation or mixture withdrawn from illegal circulation contains two or more substances subject to special control, the amount shall be determined by recalculation to the substance for whose illegal circulation (in the established amount) a stricter measure of punishment is provided.

4. The amount shall not be determined for the medicinal forms of substances included in Lists III and IV (except for the exceptional cases provided for by this Law), as well as for those preparations that are not included in the lists.

4¹. If the amount of a narcotic drug provided for by the list of Annex No. 2 to this Law is not determined, any amount thereof shall be considered the starting amount for criminal liability.

5. Changes in the small, large and especially large amounts of substances subject to special control withdrawn from illegal possession or circulation shall be made by the Parliament of Georgia taking into account the relevant recommendation of the Government of Georgia.

Law of Georgia of 4 April 2018 No. 2118 – website, 19 April 2018.

Chapter II. Competence of the State in the sphere of circulation of substances subject to special control in Georgia and state coordination of activities against their illegal circulation

Article 7. State regulation of the circulation of substances subject to special control in Georgia🔗

State regulation of the circulation of substances subject to special control in Georgia shall be carried out only by state bodies authorized for that purpose.

Article 8. State competence in the field of legal circulation of substances subject to special control in Georgia🔗

1. Control and supervision over the legal circulation of substances subject to special control shall be exercised by the relevant bodies of the executive authority of Georgia through the services authorized for that purpose.

2. The Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia shall ensure the production of prescription forms for pharmaceutical products included in List II in the required quantity.

3. Control over the legal circulation of pharmaceutical products in Georgia and the quality of narcological assistance shall be exercised only by State bodies authorized for that purpose within the scope of their competence.

4. The State shall ensure the availability of narcotic drugs and psychotropic substances in the required quantity and form, for medical, scientific and other purposes permitted by the legislation of Georgia, in accordance with international standards.

Law of Georgia of 5 July 2018 No. 3064 – website, 11.07.2018.

Article 9. Quotas for narcotic drugs, psychotropic substances and precursors🔗

1. State quotas for narcotic drugs, psychotropic substances and precursors included in Table No. 1 of List IV subject to international control (if necessary – amendments to the quotas) shall be determined by the competent body, taking into account Georgia's annual requirements, and submitted for approval to the International Narcotics Control Board of the United Nations in accordance with international requirements.

2. Fixed quotas for individual substances subject to special control, taking into account Georgia's annual requirements, may be determined jointly by the Minister of Internal Affairs of Georgia and the Minister of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia. The fixed quotas shall be submitted for approval to the International Narcotics Control Board of the United Nations in accordance with international requirements.

3. Domestic quotas for individual substances subject to special control that are not subject to international control, and for individual medicinal products equated to pharmaceutical products subject to special control, taking into account Georgia's annual requirements, may be determined jointly by the Minister of Internal Affairs of Georgia and the Minister of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia.

4. (Removed – 02.07.2025, No. 918).

5. (Removed – 02.07.2025, No. 918).

Law of Georgia of 5 March 2014 No. 2043 – website, 12.03.2014.

Law of Georgia of 5 July 2018 No. 3064 – website, 11.07.2018.

Law of Georgia of 2 July 2025 No. 918 – website, 02.07.2025.

Article 10. Packaging and labelling of pharmaceutical products subject to special control🔗

1. The conditions to be met by the packaging and labelling of pharmaceutical products subject to special control shall be determined by this Law and the Law of Georgia “On Medicines and Pharmaceutical Activity”.

2. The form of packaging of pharmaceutical products subject to special control manufactured in Georgia, as well as imported into Georgia, must exclude the possibility of contact with the medicine and/or pharmaceutical substance without violating its integrity.

Article 11. Popularisation and advertising of substances subject to special control in Georgia🔗

1. Any popularisation and advertising of substances included in the lists of substances subject to special control in Georgia is prohibited − dissemination of information on the creation, consumption and use of a narcotic drug and psychotropic substance and on the places of their acquisition, the use of books, brochures and mass media, including the Internet, for advertising purposes, except for specialised professional literature.

2. Advertising of a substance subject to special control means material and/or an action disseminated through mass media, as well as by any other means and in any form, the purpose of which is the propaganda of the use of this substance.

3. Prohibited:

a) advertising of a substance subject to special control;

b) distribution of a substance subject to special control to the population for advertising purposes.

Article 12. Reporting on activities related to the legal circulation of substances subject to special control in Georgia🔗

1. All state bodies and persons who carry out activities related to the legal circulation of substances subject to special control in the territory of Georgia shall be obliged to submit information to the competent body in accordance with the procedure approved by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia.

2. Failure to comply with the requirement provided for by paragraph 1 of this Article shall entail liability in accordance with the procedure established by the Code of Administrative Offences of Georgia.

Law of Georgia of 5 July 2018 No. 3064 – website, 11.07.2018.

Article 13. Recording of operations related to the legal circulation of pharmaceutical products subject to special control in Georgia🔗

Operations related to the legal circulation of pharmaceutical products subject to special control in Georgia shall be recorded in accordance with the legislation of Georgia.

Article 14. Interagency Coordinating Council for Combating Drug Addiction🔗

1. For the purpose of reducing the spread of drug addiction in the country and the medical, social and economic harm caused by the use of narcotic drugs, and for the purpose of ensuring effective and coordinated interagency cooperation against the illicit circulation of narcotic drugs, the Interagency Coordinating Council for Combating Drug Addiction (hereinafter – the Council) is established.

2. The organisational-legal form, composition and rules of activity of the Council shall be determined by the Council's statute, which shall be approved by the Government of Georgia.

3. The Council shall be entitled, within the scope of its competence, to request from the relevant institutions the documentation necessary for its work.

4. In its activities the Council shall be guided by the Constitution of Georgia, the international treaties and agreements of Georgia, the laws of Georgia and other normative acts.

5. For the purpose of collecting and assessing information related to the illicit use of substances subject to special control in the country, as well as introducing evidence-based scientific-practical methodologies, the Council shall ensure the creation of a system for monitoring the illicit use and illicit circulation of substances subject to special control and the promotion of its functioning.

6. The monitoring system shall ensure:

a) determination of the epidemiological and statistical indicators of the illicit use of substances subject to special control, assessment of the medical and public harm caused by illicit use and drug addiction and planning of the measures to be implemented, as well as assessment of the effectiveness of the effective measures taken;

b) exchange of information with the relevant organisations at the international level and reporting;

c) participation in the "Early Warning System".

7. The rules of functioning of the monitoring system and the institution carrying out monitoring shall be determined by the Council.

Law of Georgia of 20 September 2013 No. 1240 – website, 01.10.2013.

Chapter III. Sphere of use of substances subject to special control in Georgia

Article 15. Prohibition of certain types of circulation of substances subject to special control in Georgia🔗

1. Except for use in educational, scientific-research, expert and criminalistic activities, the following is prohibited in Georgia:

a) circulation of a narcotic drug included in List I;

b) creation of an analogue of a narcotic drug included in Lists I and II;

c) manufacture-processing of a substance subject to special control.

2. It is prohibited to bring into Georgia and take out of Georgia substances subject to special control by postal item (except for the exceptional cases provided for by this Law), as well as to the address of a post office box or a bank.

3. It is prohibited:

a) to bring in a narcotic drug to the address of a bonded warehouse / customs terminal;

b) to take out a narcotic drug to the address of a bonded customs warehouse / customs terminal, except in the case where the specific bonded customs warehouse / customs terminal is indicated in the prior agreement document issued by the competent authority of the importing country;

c) transit;

d) re-export, except in the case where an international organization carries out an activity provided for by a programme;

e) production;

f) dispatch.

4. It is also prohibited:

a) sale of a pharmaceutical product subject to special control that has not undergone serial control (serial control of a pharmaceutical product subject to special control shall be ensured by the importer);

b) purchase and/or sale by a person, through an online pharmacy, of substances subject to special control included in the lists;

c) use of a pharmaceutical product included in List II without a doctor's prescription;

d) issuance-sale of a pharmaceutical substance to a natural person;

e) activity related to the circulation in Georgia of a pharmaceutical product subject to special control by a person convicted of a drug crime, a person suffering from drug addiction and/or an unlawful user of narcotic drugs;

f) sowing, growing and cultivating a plant and mushroom mycelium containing a substance subject to special control.

Article 16. Use of pharmaceutical products subject to special control for the purpose of providing emergency medical assistance🔗

1. The Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia shall determine the list and quantity of pharmaceutical products subject to special control whose use for the purpose of providing emergency medical assistance is permitted on air, sea and railway transport registered in the territory of Georgia, including when performing international flights.

2. When performing an international flight by any transport, when holding an international event (velosport, autorally and others), including joint military training with a representative of a foreign country, accordingly, for passengers and persons participating in the event, for the purpose of providing emergency medical assistance, it is permitted (if the event to be held provides for this) to bring into Georgia and take out of Georgia pharmaceutical products subject to special control included in Lists II and III. This process is not considered import, export or transit.

3. Before the start of the international event provided for by paragraph 2 of this article, the interested organization (agency) shall apply in writing to the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia, on the basis of which the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia shall issue a corresponding letter addressed to the Legal Entity of Public Law – Revenue Service within the governance sphere of the Ministry of Finance of Georgia, which is the basis for the passage or refusal of passage of pharmaceutical products subject to special control.

Law of Georgia of 5 July 2018 No. 3064 – website, 11.07.2018.

Article 17. Use of substances subject to special control in educational, scientific-research, expert and forensic activities🔗

In educational, scientific-research, expert and forensic activities, the use of substances subject to special control by a state institution and by a legal entity authorized by a competent body is permitted.

Article 18. Rules of legal circulation in Georgia of substances subject to special control for veterinary activities🔗

The rules of legal circulation in Georgia of substances subject to special control necessary for the activities of veterinary services and animal capture shall be approved, in agreement with the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia, by the Minister of Environmental Protection and Agriculture of Georgia.

Law of Georgia of 7 December 2017 No. 1644 – website, 14.12.2017.

Law of Georgia of 5 July 2018 No. 3064 – website, 11.07.2018.

Article 19. Bringing into Georgia and Taking out of Georgia of a Pharmaceutical Product Subject to Special Control for the Individual Needs of a Natural Person🔗

1. A natural person (including a natural person in transit through the territory of Georgia) shall have the right to carry with them, for treatment purposes, narcotic drugs and psychotropic substances together with the appropriate medical documents and documents related to the movement of goods across the customs border of Georgia.

2. If a natural person cannot leave the territory of Georgia but needs a pharmaceutical product subject to special control to continue treatment, the provision of the patient with the appropriate medications shall be carried out in accordance with the procedure approved by the Minister of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia.

3. The bringing into Georgia, taking out of Georgia, or movement through the territory of Georgia to the territory of another state, by a natural person (including a natural person in transit through the territory of Georgia), of a pharmaceutical product subject to special control for individual needs shall not be considered import, export or transit of a pharmaceutical product subject to special control.

4. The procedure for bringing into Georgia and taking out of Georgia, by a natural person, of a pharmaceutical product subject to special control for individual needs shall be approved by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia in agreement with the Legal Entity of Public Law within the governance sphere of the Ministry of Finance of Georgia – the Revenue Service.

Law of Georgia No. 3064 of 5 July 2018 – website, 11 July 2018.

Chapter IV. Implementation of Certain Types of Activities Related to the Circulation of Substances Subject to Special Control

Article 20. Permit-requiring Activities Related to the Legal Circulation of Pharmaceutical Products Subject to Special Control and Basic Requirements Related to the Issuance of a Permit🔗

1. Permit-requiring activities related to the legal circulation of pharmaceutical products subject to special control shall be regulated in accordance with the Law of Georgia “On Licenses and Permits” and subordinate normative acts issued on its basis.

2. The use by a medical service provider of a pharmaceutical product subject to special control that is part of medical services shall not require a permit.

Article 21. Production of Pharmaceutical Products Subject to Special Control🔗

Only a legal entity holding the relevant permit shall have the right to produce pharmaceutical products subject to special control included in Schedules III and IV.

Article 22. Preparation in a pharmacy of a pharmaceutical product subject to special control🔗

1. A pharmacy holding the relevant permit shall have the right to prepare a pharmaceutical product subject to special control according to a magistral prescription.

2. A pharmacy shall be prohibited from preparing a pharmaceutical product subject to special control according to an officinal prescription.

3. A pharmacy holding the relevant permit shall have the right to prepare, according to an officinal prescription, a preparation containing a psychotropic substance included in List III which is not included in the lists.

Article 23. Manufacture - processing of substances subject to special control🔗

Only educational, scientific-research, expert and criminalistics institutions authorized for that purpose shall have the right to manufacture and process substances subject to special control.

Article 24. Storage in Georgia of substances subject to special control🔗

1. A person carrying out the relevant activity shall have the right to store substances subject to special control in accordance with the procedure established by the legislation of Georgia, as well as a natural person, if the pharmaceutical product subject to special control was purchased on the basis of a physician's prescription.

2. In Georgia, the storage of narcotic drugs in a customs warehouse using the customs warehouse procedure shall be prohibited.

Law of Georgia of 28 June 2019 No. 4915 – website, 04.07.2019.

Article 25. Purchase of a pharmaceutical product subject to special control🔗

The right to purchase a pharmaceutical product subject to special control shall be held by:

a) a natural person (only on the basis of the relevant prescription);

b) a person holding the relevant right from a person holding the relevant right (on the basis of documentation established by the legislation of Georgia), for the purpose of carrying out an activity permitted by the legislation of Georgia.

Article 26. Dispatch of substances subject to special control🔗

On the territory of Georgia, the dispatch of substances subject to special control included in Lists I and II shall be prohibited.

Article 27. Transportation (carriage) of substances subject to special control🔗

1. The right to transport (carry) substances subject to special control shall be held by a legal entity authorized to circulate these substances, together with documentation confirming their purchase.

2. Transportation by a legal entity of a pharmaceutical product subject to special control included in List II shall be carried out only with police escort.

3. A natural person shall have the right to carry a pharmaceutical product subject to special control included in List II together with a document confirming its purchase. The form and procedure for issuing such a document shall be approved by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia.

Law of Georgia of 5 July 2018 No. 3064 – website, 11.07.2018.

Article 28. Retail sale of a pharmaceutical product subject to special control🔗

A person holding the relevant permit shall have the right to retail sale of a pharmaceutical product subject to special control to an individual, on the basis of a prescription established by legislation.

Article 29. Wholesale sale of substances subject to special control🔗

Only a legal entity holding the relevant permit that is founded by the State or by a legal entity founded by the State/under the management of the State shall have the right to carry out wholesale sale of substances subject to special control, on the basis of documentation established by the legislation of Georgia.

Law of Georgia of 2 July 2025 No. 918– website, 02.07.2025.

Article 30. Import (Export) of a Pharmaceutical Product Subject to Special Control🔗

1. The right to import (export) a pharmaceutical product subject to special control shall be vested only in a legal entity having the relevant activity and permit.

1¹. The right to import narcotic drugs and psychotropic substances in accordance with the rules established by this Article shall be vested only in a legal entity founded by the State or by a legal entity founded by the State/under State management.

1². The Minister of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia shall be authorized, if necessary, to grant the right to import narcotic drugs and psychotropic substances to another legal entity.

2. Before the import (export) of a narcotic drug, the importing (exporting) legal entity shall be obliged to obtain prior agreement and a permit issued by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia.

3. Before importing or exporting psychotropic substances and precursors included in Table No. 1 of List IV, a legal entity shall be obliged to obtain prior agreement and a permit issued by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia.

4. In the event of an attempt to bring a narcotic drug into Georgia without a prior permit or to import a psychotropic substance without a prior permit, the relevant service of the Ministry of Finance of Georgia shall ensure the return of the cargo at the supplier's expense.

5. Before the issuance of the permit certificate, the import (export) of a pharmaceutical product subject to special control shall be agreed in advance with the competent authority of the exporting (importing) country, for which the competent authority shall issue a prior agreement document.

6. Prior agreement shall be required for the import (export) of any substance subject to special control, as well as for the export of preparations produced in Georgia, regardless of whether or not they are included in the lists.

7. A prior agreement document shall also be issued if the manufacturer and/or the exporting (importing) country so requires, regardless of whether or not the pharmaceutical product subject to special control is subject to special control in Georgia.

8. The prior agreement document shall specify:

a) name of the importing (exporting) organization, its legal and actual addresses;

b) international non-proprietary (generic) and trade names of the substance subject to special control (if any);

c) import (export) quantity (in the case of import or export of a substance subject to special control – dosage form, dosage unit, quantity);

d) type of transport by which the cargo is brought into Georgia (taken out of Georgia);

e) purpose of import (export);

f) the date of issue and the validity period of the document.

9. In the case of export, the pre-agreement document shall additionally indicate the number of the prior import agreement document issued by the relevant national competent authority of the importing country and the date of its issue.

10. Within the framework of this rule, the export of those pharmaceutical products subject to special control whose registration period in Georgia has expired shall be permitted.

1¹. Legal entities authorised to carry out educational, scientific-research, expert and forensic activities shall be entitled to import substances subject to special control, respectively, only for the purpose of carrying out educational, scientific-research, expert and forensic activities. In this case, the import shall be carried out only on the basis of a pre-agreement document and shall not require the issuance of an additional permit document.

1². The export of those preparations produced in Georgia which are not included in the lists shall be carried out on the basis of a pre-agreement document and shall not require the issuance of an additional permit certificate.

13. Immediately upon completion of the import (export) operation, the relevant customs authority shall, in accordance with the procedure established by the legislation of Georgia, provide the competent authority with information on the import (export) of substances subject to special control, indicating the names and quantities of the substances actually imported (exported) and the date of the import (export).

14. Where the relevant authority of the exporting country applies to the competent authority, the latter shall, in accordance with the procedure provided for by international norms, provide it with information on the names and quantities of the substances actually imported.

15. A narcotic drug brought into Georgia and to be taken out of Georgia, as well as a psychotropic substance intended for import or export, which are not accompanied by a pre-agreement document issued by the relevant authority, shall be detained by the customs authority.

16. After the performance of an export operation of a pharmaceutical product subject to special control, the competent authority shall, in accordance with the procedure provided for by international norms, request from the authorised authority of the importing country information on the name and quantity of the pharmaceutical product actually imported and the date of the import.

17. Where, during the customs procedure of release for free circulation or export, a discrepancy is detected between the actual quantity of a pharmaceutical product subject to special control and the quantity indicated in the permit certificate, the customs authority shall detain the goods and notify the competent authority thereof, after which the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia and the relevant services of the Ministry of Finance of Georgia shall, within the scope of their competence, examine the causes and act in accordance with the procedure established by the legislation of Georgia.

18. The rules for the import and export of narcotic drugs and psychotropic substances shall be approved by a joint order of the Minister of Finance of Georgia and the Minister of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia.

19. The rules for carrying out the import and export of precursors included in List IV shall be approved by the Government of Georgia.

20. The list of those customs checkpoints located in the territory of Georgia through which the entry into Georgia and the exit from Georgia of substances subject to special control is permitted shall be determined by the Legal Entity of Public Law – Revenue Service, falling within the governance sphere of the Ministry of Finance of Georgia, in accordance with the procedure established by the legislation of Georgia.

2¹. By postal item, the following shall be permitted:

a) the entry into Georgia and the exit from Georgia of a substance subject to special control for expert purposes;

b) the import and export of registration samples, reference standards and standard reference samples provided for by the Law of Georgia “On Medicines and Pharmaceutical Activity”.

22. During a natural disaster or other emergency situation in Georgia, the entry into Georgia (exit from Georgia) of a pharmaceutical product subject to special control shall be carried out without prior agreement. In this case, the control regime provided for by the legislation of Georgia shall apply to the legal circulation of the medicinal product subject to special control imported at that time.

23. In free ports and zones (free industrial zones), the same supervision and control shall be imposed on the circulation of substances subject to special control as in other parts of the territory of Georgia, however, the adoption of stricter measures shall also be permissible.

Law of Georgia of 5 March 2014 No. 2043 – website, 12.03.2014.

Law of Georgia of 5 July 2018 No. 3064 – website, 11.07.2018.

Law of Georgia of 28 June 2019 No. 4915 – website, 04.07.2019.

Law of Georgia of 2 July 2025 No. 918 – website, 02.07.2025.

Article 31. Purchase, storage, recording and issuance of a special prescription form for prescribing a pharmaceutical product subject to special control, and prescribing of a prescription🔗

1. Prescribing of a pharmaceutical product subject to special control is permitted on a special prescription form approved by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia, in material or electronic form.

2. The Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia shall approve the rules for the purchase, storage, recording and issuance of a special prescription form for prescribing and for the prescribing of a prescription.

3. The Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia shall approve the list of pharmaceutical products to be prescribed on a special prescription form (including those pharmaceutical products subject to special control that are not included in the lists).

4. A doctor holding the relevant certificate has the right to prescribe, on a special prescription form, a pharmaceutical product subject to special control that is included in the lists and registered in Georgia.

5. For the individual need of a natural person, the prescribing of a pharmaceutical product subject to special control that is not registered in Georgia, in accordance with the procedure established by the legislation of Georgia, is permitted.

Law of Georgia of 5 July 2018 No. 3064 – website, 11 July 2018.

Article 32. Destruction of substances subject to special control🔗

1. The following shall be subject to destruction:

a) substances subject to special control, included in the lists, seized by law enforcement bodies from illegal circulation or from possession, plants containing narcotic drugs and psychotropic substances, except for the case provided for by paragraph 3 of this Article;

b) pharmaceutical products subject to special control issued for the treatment of a patient and returned;

c) residues of substances subject to special control used in medical, expert, educational and veterinary activities;

d) expired and/or rendered unusable as a result of any impact substances subject to special control;

e) substances subject to special control — in other cases established by the legislation of Georgia.

2. Substances subject to special control in Georgia shall be destroyed by a legal entity or a state body authorized for that purpose.

3. Substances subject to special control, included in the lists, seized by law enforcement bodies from illegal circulation or from possession, plants containing narcotic drugs and psychotropic substances may, on the basis of a petition of the relevant administrative body, be transferred to that administrative body for educational/training or scientific-research purposes. The rule for the transfer, storage, use and destruction of substances subject to special control, included in the lists, seized from illegal circulation or from possession, and plants containing narcotic drugs and psychotropic substances for the said purpose shall be determined by a Resolution of the Government of Georgia.

Law of Georgia of 19 December 2019 No. 5622 – website, 26 December 2019.

Chapter V. Restrictions in respect of persons suffering from drug addiction

Article 33. Restrictions established on professions and activities🔗

1. For the purposes of ensuring state and public security, protecting the health of natural persons, moral values, human rights and other legitimate interests, restrictions on particular professions and activities are established in Georgia with respect to persons dependent on substances subject to special control included in Lists I, II and III and to illegal users of substances subject to special control included in Lists I and II.

2. The list of professions and activities provided for by paragraph 1 of this Article shall be approved, and the periodicity of narcological testing shall be determined, by the Government of Georgia.

3. For persons carrying out the activities and for representatives of the professions established in accordance with paragraph 1 of this Article, periodic testing for the fact of use of substances subject to special control included in Lists I, II and III shall be mandatory. For workers of the said professions, the fact of illegal use of substances subject to special control included in Lists I and II shall be grounds for dismissal from service, except where the person uses a pharmaceutical product subject to special control for treatment purposes, by prescription of a doctor with the appropriate authority, and there is medical documentation confirming this.

Chapter VI. Narcological assistance

Article 34. General principles of narcological assistance🔗

1. Treatment and rehabilitation programmes for a person suffering from drug addiction, and for users of substances subject to special control included in Schedules I, II and III, shall be financed from the State Budget of Georgia and/or from the revenues permitted by the legislation of Georgia of a Legal Entity of Public Law subordinate to the control of the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia.

2. A person suffering from drug addiction, a user of substances subject to special control included in Schedules I, II and III, shall be provided with narcological assistance in the relevant institution providing narcological services, openly, confidentially or anonymously, voluntarily. A minor patient shall be provided with narcological assistance in accordance with the procedure established by the legislation of Georgia.

3. Treatment of a person suffering from drug addiction, a user of substances subject to special control included in Schedules I, II and III, with narcotic drugs is prohibited, except in cases of vital indications, in inpatient conditions, in accordance with the relevant standard, guideline or protocol, during the period of withdrawal from narcotic dependence, as well as for the implementation of a special drug substitution programme.

3¹. Only a legal entity founded by the State or by a legal entity founded by the State/under the management of the State shall have the authority to carry out opioid substitution treatment. Opioid substitution treatment shall be carried out in accordance with the technical regulation approved by a Resolution of the Government of Georgia and the legislation of Georgia.

4. The methodology of treatment under the special drug substitution programme shall be determined by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia.

5. The types of compulsory medical assistance for a person suffering from drug addiction are:

a) withdrawal from narcotic dependence in the case of temporary restriction of liberty or being in pre-trial detention;

b) treatment in a penitentiary institution.

6. The rules of examination, inspection, expert examination, diagnosis, treatment, rehabilitation and supervision of a person suffering from drug addiction, a user of substances subject to special control included in Schedules I, II and III, shall be determined by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia.

Law of Georgia of 1 May 2015 No. 3553 – website, 18.05.2015.

Law of Georgia of 5 July 2018 No. 3064 – website, 11.07.2018.

Law of Georgia of 2 July 2025 No. 918 – website, 02.07.2025.

Article 35. Institution providing narcological services🔗

The institution providing narcological services provides narcological and medical-psychological assistance to a user of substances subject to special control included in Lists I, II and III and to a person suffering from drug addiction. A medical institution that provides this service in inpatient and/or outpatient settings, in accordance with the requirements established by the legislation of Georgia, is classified as an institution providing narcological services.

Article 36. Identification and registration of a person suffering from drug addiction and establishment of the fact of intake of substances included in Schedules I, II and III subject to special control🔗

1. The fact of intake of substances included in Schedules I, II and III subject to special control shall be established on the basis of clinical and/or laboratory examination.

2. The rule for establishing being under the use/exposure of substances included in Schedules I, II and III subject to special control shall be determined by a joint order of the Minister of Internal Affairs of Georgia and the Minister of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia.

3. The institution authorised by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia shall create a unified information bank of persons suffering from drug addiction and users of substances subject to special control in Georgia.

4. The rule of functioning of the unified information bank and the list of those state bodies and legal entities for which the information placed in the unified information bank must be accessible shall be established by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia.

5. Information about persons suffering from drug addiction in Georgia and users of substances included in Schedules I, II and III subject to special control shall be placed in the unified information bank of persons suffering from drug addiction and users of substances subject to special control in Georgia. The information placed in the bank is confidential.

6. All state bodies, legal entities and individual entrepreneurs that carry out examination, diagnosis, screening and rehabilitation measures in respect of users of narcotic drugs and psychotropic substances and persons suffering from drug addiction in the territory of Georgia shall be obliged to keep their registration in accordance with the established rule and, within the established time limits, provide information to the unified information bank.

7. In the case of anonymous service and/or treatment, the institution providing narcological service shall have the right to send information to the unified information bank without personal data. Such data constitute medical secrecy, the disclosure of which occurs only with the patient's consent or in accordance with the rule established by the legislation of Georgia.

8. Diagnosis of a person suffering from drug addiction shall be carried out by the institution providing narcological service or an institution with the relevant authority, by a commission procedure, with the participation of not less than 3 physician-narcologists, as a result of which a registration card established by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection of Georgia shall be drawn up in two copies in respect of the person suffering from drug addiction. One copy shall be sent to the unified information bank, and the other shall remain at the institution.

Law of Georgia of 5 July 2018 No. 3064 – website, 11.07.2018.

Law of Georgia of 16 November 2021 No. 1014 – website, 22.11.2021.

Article 37. Treatment of a Person Suffering from Drug Addiction🔗

1. A person suffering from drug addiction shall undergo treatment at an institution providing narcological services, in accordance with the established standard or the national clinical practice recommendation (guideline) approved or recognised by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia and the state standard (protocol) for the management of the clinical condition.

2. In the case of voluntary treatment at his/her own expense, a person suffering from drug addiction has the right to retain anonymity in accordance with the established procedure. Information on treatment financed from the State Budget of Georgia is confidential.

3. In the case of anonymous treatment, a person suffering from drug addiction is obliged to present an identity document to the medical institution in accordance with the established procedure. On the basis of such document, he/she is assigned a special code, the decryption of which is carried out with his/her consent or by a court judgment, in accordance with the procedure established by the legislation of Georgia.

[ 2. In the case of voluntary treatment at his/her own expense, a person suffering from drug addiction has the right to retain anonymity in accordance with the established procedure, except for the cases provided for by paragraph 3 of this Article. The data of the said person related to treatment financed from the State Budget of Georgia are confidential, and only the relevant institutions have the right to obtain them in the cases determined by law.

3. In the case of anonymous treatment, a person suffering from drug addiction is obliged to present an identity document to the medical institution in accordance with the established procedure. On the basis of this document, the said person is assigned a special code, the decryption of which is carried out with his/her consent or by a court judgment, in accordance with the procedure established by the legislation of Georgia. The identification of this person is also permissible in the cases determined by law. (shall enter into force from 1 May 2026)]

4. The rules for the submission of an identity document by the patient, the assignment of a special code to him/her and the protection of confidentiality shall be established by the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia.

Law of Georgia of 5 July 2018 No. 3064 – website, 11.07.2018.

Law of Georgia of 9 December 2025 No. 1153 – website, 15.12.2025.

Chapter VII. Transitional Provisions

Article 38. Measures to be taken in connection with the entry into force of the Law🔗

1. After the entry into force of this Law, legal acts adopted before the entry into force of this Law shall retain legal force, unless they contradict this Law.

2. Within 8 months from the entry into force of this Law, the Ministry of Labour, Health and Social Protection of Georgia shall, in agreement with the relevant bodies of the executive authority of Georgia, approve the relevant legal acts necessary for the entry into force of this Law.

3. The Ministry of Agriculture of Georgia shall, in agreement with the Ministry of Labour, Health and Social Protection of Georgia, develop and approve:

a) the rules for the use in Georgia of substances subject to special control, necessary for the activities of the veterinary service and the capture of animals;

b) the rules for sowing, growing and cultivating the mycelium of plants and fungi containing narcotic drugs, psychotropic substances and precursors for scientific-research purposes.

4. Within 6 months from the entry into force of this Law, the Ministry of Labour, Health and Social Protection of Georgia, together with the Ministry of Justice of Georgia, shall develop and submit to the Government of Georgia for approval the list of individual professions and activities in the pursuit of which a narcological examination is necessary, and the rules for periodic examination, on the principle of random selection, for the fact of the use of substances included in Schedules I and II of substances subject to special control.

5. Within 3 months from the entry into force of this Law, the Interagency Coordinating Council for Combating Drug Addiction shall develop the rules for the functioning of the monitoring system.

Article 39. Normative acts to be repealed in connection with the entry into force of the Law🔗

Upon the entry into force of this Law, the following shall be declared invalid:

a) the Law of Georgia of 5 December 2002 "On Narcotic Drugs, Psychotropic Substances, Precursors and Narcological Assistance" (Legislative Herald of Georgia, No. 33, 23.12.2002, Art. 162);

b) Resolution No. 2557-rs of the Parliament of Georgia of 23 July 2003 "On approval of the 'List of small, large and especially large amounts of narcotic drugs and psychotropic substances withdrawn from illegal possession or circulation'" (Legislative Herald of Georgia, No. 82, 6.08.2003, Art. 727).

Chapter VIII. Final provision

Article 40. Entry of the Law into Force🔗

This Law shall enter into force on the 30th day after publication.

President of Georgia M. Saakashvili

Tbilisi,

22 May 2012.

No. 6245-Is

Annex No. 1

List I

Narcotic substances strictly restricted for circulation

No.

Name of substance

Chemical name

(+)-Lysergide (LSD, LSD-25)

(+)-LYSERGIDE (LSD, LSD-25)

9,10-didehydro-N,N-diethyl-6-methylergoline-8 β -carboxamide

(removed - 16.04.2014, No. 2235)

3-Methylthiofentanyl

3-METHYLTHIOFENTANYL

N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl] propionanilide

3-Methylfentanyl

3-METHYLFENTANYL

N-(3-methyl-1-phenethyl-4-piperidyl)propionanilide

(removed - 16.04.2014, No. 2235)

4-Methylaminorex

4-METHYLAMINOREX

(±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline

211

4,4’-DMAR, 4,4’Dimethylaminorex

para-methyl-4-methylaminorex

212

4-Methylethcathinone

4-METHYLETHCATHINONE

(4-MEC)

213

5F-APINACA

(5F-AKB-48)

214

4-Fluoroisobutyrfentanyl

(4-FIBF, pFIBF)

N-(4-Fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide

215

4-Fluoroamphetamine

(4-FA)

1-(4-Fluorophenyl)propan-2-amine

216

5F-MDMB-PINACA

(5F-ADB)

Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate

217

5F-PB-22

Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

218

4-CMC (clephedrone)

4-CMC (4-chloromethcathinone; clephedrone)

1-(4-chlorophenyl)-2-(methylamino)-1-propanone

219

4F-MDMB-BINACA

Methyl(S)-2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate

2110

5F-AMB-PINACA

(5F-AMB, 5F-MMB-PINACA)

Methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3yl]carbonyl}amino)-3-methylbutanoate

2111

5F-MDMB-PICA

(5F-MDMB-2201)

Methyl(S)-2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate

2112

3-Methoxyphencyclidine

1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine

(removed - 16.04.2014, No. 2235)

271

N-Ethylnorpentylone (Ephylone)

N-ETHYLNORPENTYLONE (Ephylone)

1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one

272

N-Ethylhexedrone

N-ethylhexedrone

2-(Ethylamino)-1-phenyl-1-hexanone

N-Hydroxy MDA

N-HYDROXY MDA

(±)-N[ α -methyl-3,4-(methylenedioxy)phenethyl] hydroxylamine

281

ADB-FUBINACA

N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

282

ADB-CHMINACA

(MAB-CHMINACA)

ADB-CHMINACA

(MAB-CHMINACA)

N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-

(cyclohexylmethyl)-1H-indazole-3-carboxamide

283

Acryloylfentanyl (Acrylfentanyl)

Acryloylfentanyl

(Acrylfentanyl)

N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide

284

AB-CHMINACA

N-[(2S)-1-Amino-3-methyl-1-oxobutan-2yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

285

AB-PINACA

N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide

286

AB-FUBINACA

N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide

Alphamethadol

ALPHAMETHADOL

α-6-dimethylamino-4,4-diphenyl-3-heptanol

alpha-methyl-4-methylthiophenethylamine

4-MTA

α-methyl-4-methylthiophenethylamine

alpha-methylthiofentanyl

ALPHA-METHYLTHIOFENTANYL

N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl] propionanilide

alpha-methylfentanyl

ALPHA-METHYLFENTANYL

N-[1-(α -methylphenethyl)-4-piperidyl]propionanilide

Alphameprodine

ALPHAMEPRODINE

α -3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine

331

alpha-PVP

α-PVP

α-pyrrolidinovalerophenone

332

alpha-PHP

(RS)-1-Phenyl-2-(pyrrolidine-1-yl)hexan-1-one

Alphacetylmethadol

ALPHACETYLMETHADOL

α-3-acetoxy-6-dimethylamino-4,4-diphenylheptane

341

AH-7921

3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide

acetyl-alpha-methylfentanyl

ACETYL-ALPHA-METHYLFENTANYL

N-[1-(α-methylphenethyl)-4-piperidyl]acetanilide

Acetylmethadol

ACETYLMETHADOL

3-acetoxy-6-dimethylamino-4,4-diphenylheptane

361

Acetylfentanyl

N-[1-(2-phenylethyl)-4-piperidyl]-N-phenylacetamide

Acetorphine

ACETORPHINE

3-O-acetyltetrahydro-7 α -(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine

(derivative of thebaine)

Bezitramide

BEZITRAMIDE

1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)piperidine

Benzethidine

BENZETHIDINE

1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester

Benzylmorphine

BENZYLMORPHINE

3-benzylmorphine

401

Benzylpiperazine

N-BENZYLPIPERAZINE (Benzylpiperazine, BZP)

1-benzylpiperazine

Betamethadol

BETAMETHADOL

β-6-dimethylamino-4,4-diphenyl-3-heptanol

Betameprodine

BETAMEPRODINE

β -3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine

Betaprodine

BETAPRODINE

β-1,3-dimethyl-4-phenyl-4-propionoxypiperidine

Betacetylmethadol

BETACETYLMETHADOL

β-3-acetoxy-6-dimethylamino-4,4-diphenylheptane

beta-hydroxy-3-methylfentanyl

BETA-HYDROXY-3-METHYLFENTANYL

N-[1-(β -hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide

beta-hydroxyfentanyl

BETA-HYDROXYFENTANYL

N-[1-(β -hydroxyphenethyl)-4-piperidyl]propionanilide

(deleted – 16.04.2014, No. 2235)

Brolamfetamine

BROLAMFETAMINE (DOB)

(±)-4-bromo-2,5-dimethoxy-α-methylphenethylamine

49¹

Butyrfentanyl

BUTYRFENTANYL

N -phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] butanamide

49²

Brorphine

BRORPHINE

1-{1-[1-(4-bromophenyl)ethyl]-piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one

(deleted – 16.04.2014, No. 2235)

Desomorphine

DESOMORPHINE

Dihydrodesoxymorphine

(derivative of morphine)

DET

3-[2-(diethylamino)ethyl]indole

Diampromide

DIAMPROMIDE

N-[2-(methylphenethylamino)-propyl]propionanilide

58¹

Diclazepam

7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin2-one

(deleted – 16.04.2014, No. 2235)

Dimepheptanol

DIMEPHEPTANOL

6-dimethylamino-4,4-diphenyl-3-heptanol

Dihydroetorphine

DIHYDROETORPHINE

7,8-dihydro-7 α -[1-(R)-hydroxy-1-methylbutyl]-6,14-endo-ethanotetrahydrooripavine

(derivative of etorphine)

Dihydromorphine

DIHYDROMORPHINE

(derivative of morphine)

62¹

Diphenidine

1-(1,2-Diphenylethyl)piperidine

DMA

(±)-2,5-dimethoxy-α-methylphenethylamine

DMT

3-[2-(dimethylamino)ethyl]indole

DMHP

3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol

DOET

(±)-4-ethyl-2,5-dimethoxy-α-methylphenethylamine

66¹

DOC

4-Chloro-2,5-dimethoxyamfetamine

(deleted – 16.04.2014, No. 2235)

Ecgonine

ECGONINE

its esters and derivatives which are convertible to ecgonine and cocaine

(deleted – 16.04.2014, No. 2235)

Ethylmethylthiambutene

ETHYLMETHYLTHIAMBUTENE

3-ethylmethylamino-1,1-di-(2’-thienyl)-1-butene

71¹

Ethylone

ETHYLONE

71²

Ethylphenidate

ETHYLPHENIDATE

(deleted – 16.04.2014, No. 2235)

72¹

Eutylone

1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)butan-1-one

Eticyclidine

ETICYCLIDINE (PCE)

N-ethyl-1-phenylcyclohexylamine

Etonitazene

ETONITAZENE

1-diethylaminoethyl-2-p-ethoxybenzyl-5-nitrobenzimidazole

Etorphine

ETORPHINE

tetrahydro-7 α -(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine

(derivative of thebaine)

(deleted – 16.04.2014, No. 2235)

Etryptamine

ETRYPTAMINE

3-(2-aminobutyl)indole

77¹

Valerylfentanyl

VALERYLFENTANYL

N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide

Thiofentanyl

THIOFENTANYL

N-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide

78¹

Isotonitazene

N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine

Isomethadone

ISOMETHADONE

6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone

791

XLR-11

(removed – April 16, 2014, No. 2235)

Cathinone

CATHINONE

(–)-(S)-2-aminopropiophenone

Cannabis

CANNABIS

“Cannabis” means the flowering or fruiting tops of the cannabis plant (excluding theseeds and leaves when not accompanied by the tops) from which the resin has not been extracted, by whatever name they may be designated.

Cannabis (Cannabis) − the tops of the cannabis plant with flowers and fruit (except leaves and seeds which are not accompanied by the tops of the plant), if no resin of any designation has been extracted from them

Extracts and tinctures of cannabis

(EXTRACTS AND TINCTURS OF CANNABIS)

Cannabis oil

(CANNABIS OIL)

The oil of cannabis derivedin any way

Oil obtained from the cannabis plant in any way

Cannabis resin

(CANNABIS RESIN)

Crude and/or purified cannabis resin obtained from the cannabis plant

Resin extracted from the cannabis plant, purified and/or unpurified

851

Carfentanil

Methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate

Ketobemidone

KETOBEMIDONE

4-m-hydroxyphenyl-1-methyl-4-propionylpiperidine

861

Clonazolam

6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine

Codoxime

CODOXIME

dihydrocodeinone-6-carboxymethyloxime

(derivate of morphine)

(derivative of morphine)

Coca leaf

COCA LEAF

the leaf of the coca bush (plant material), except a leaf from which all ecgonine, cocaine and any other ecgonine alkaloids have been removed

Coca leaf means the leaf of the coca bush, except those leaves from which ecgonine, cocaine and any other ecgonine alkaloid have been completely removed

881

Cumyl-4CN-BINACA

CUMYL-4CN-BINACA

1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

882

Crotonylfentanyl

CROTONYLFENTANYL

(E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide

883

Cumyl-PEGACLONE

CUMYL-PEGACLONE

5-Pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one

(removed – April 16, 2014, No. 2235)

Levomethorphan

LEVOMETHORPHAN

(-)-3-methoxy-N-methylmorphinan

Levomoramide

LEVOMORAMIDE

(-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine

Levophenacylmorphan

LEVOPHENACYLMORPHAN

(-)-3-hydroxy-N-phenacylmorphinan

Lysergic acid

LYSERGIC ACID

((8ß)-9,10-didehydro-6-methylergoline-8-carboxylic acid)

(removed – April 16, 2014, No. 2235)

MDE, N-ethyl MDA

MDE, N-ETHYL MDA

(±)-N-ethyl- α -methyl-3,4-(methylenedioxy) phenethylamine

MDMA

(±)-N, α -dimethyl-3,4-(methylenedioxy) phenethylamine

961

MDPV

MDPV (3,4-Methylenedioxypyrovalerone)

(R/S)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one

962

MDMB-CHMICA

963

MDMB-4en-PINACA

Methyl3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3- carboxamido)butanoate

(removed – 16 April 2014, No. 2235)

100

Methadone synthesis intermediate

METHADONE INTERMEDIATE

4-cyano-2-dimethylamino-4,4-diphenylbutane

101

Methyldesorphine

METHYLDESORPHINE

6-methyl- Δ 6-deoxymorphine

(derivative of morphine)

102

Methyldihydromorphine

METHYLDIHYDROMORPHINE

6-methyldihydromorphine

(derivative of morphine)

1021

Methylone

METHYLONE (Beta-keto-MDMA)

(RS)-2-methylamino-1-(3,4-methylenedioxyphenyl) propan-1-one

1022

Methiopropamine METHIOPROPAMINE

(MPA)

103

(removed – 16 April 2014, No. 2235)

104

Methcathinone (ephedrone)

METHCATHINONE (EPHEDRONE)

2-(methylamino)-1-phenylpropan-1-one

1041

Methoxetamine

METHOXETAMINE (MXE)

2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone-2-one

1042

Methoxyacetylfentanyl Methoxyacetylfentanyl

2-Methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide

105

(removed – 16 April 2014, No. 2235)

106

Mescaline

MESCALINE

3,4,5-trimethoxyphenethylamine

107

Metazocine

METAZOCINE

2'-hydroxy-2,5,9-trimethyl-6,7-benzomorphan

1071

Mephedrone

MEPHEDRONE (4-methylmethcathinone)

(RS)-2-methylamino-1-(4-methylphenyl) propan-1-one

1072

Metonitazene

METONITAZENE

N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine

108

(removed – 16 April 2014, No. 2235)

109

Metopon

METOPON

5-methyldihydromorphinone

(derivative of morphine)

110

(removed – 16 April 2014, No. 2235)

111

(removed – 16 April 2014, No. 2235)

112

Myrophine

MYROPHINE

Myristylbenzylmorphine

(derivate of morphine)

(derivative of morphine)

113

MMDA

5-methoxy- α -methyl-3,4-(methylenedioxy) phenethylamine

114

Moramide synthesis intermediate

MORAMIDE INTERMEDIATE

2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid

115

Morpheridine

MORPHERIDINE

1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester

116

Morphine-N-oxide

MORPHINE-N-OXIDE

(derivate of morphine)

(derivative of morphine)

117

Morphine methobromide and other pentavalent nitrogen morphine derivatives, including in particular the morphine-N-oxide derivatives, one of which is codeine-N-oxide

MORPHINE METHOBROMIDE AND OTHER PENTAVALENT NITROGEN MORPHINE DERIVATIVES INCLUDING IN PARTICULAR THE MORPHINE-N-OXIDE DERIVATIVES, ONE OF WHICH IS CODEINE-N-OXIDE

1171

MT-45

1-cyclohexyl-4-(1,2-diphenylethyl)piperazine

118

MPPP

1-methyl-4-phenyl-4-piperidinol propionate (ester)

119

(removed – 16 April 2014, No. 2235)

120

(removed – 16 April 2014, No. 2235)

121

(removed – 16 April 2014, No. 2235)

122

(removed – 16 April 2014, No. 2235)

123

(removed – 16 April 2014, No. 2235)

124

Noracymethadol

NORACYMETHADOL

(±)-α-3-acetoxy-6-methylamino-4,4-diphenylheptane

125

Norlevorphanol

NORLEVORPHANOL

(-)-3-hydroxymorphinan

126

Normorphine

NORMORPHINE

demethylmorphine

(derivate of morphine)

(derivative of morphine)

1261

Norfentanyl

(Propanamide, N-phenyl-N-4-piperidinyl-)

HS code: 2933.39

CAS number: 1609-66-1

127

(removed – 16 April 2014, No. 2235)

128

Opium (Amfion)

OPIUM

The coagulated juice of the opium poppy (plant species Papaver somniferum L.)

The coagulated juice of the opium poppy (plant species Papaver somniferum L)

129

Extract opium,

including:

a) aqueous extract, decoction, expressed juice, tincture obtained from any species of plant containing narcotic drugs (morphine, codeine, thebaine, oripavine), or the dry residue obtained as a result of evaporation;

b) narcotically active alkaloids obtained by any means from the opium poppy;

c) any preparation made artisanally from poppy straw

130

Opium extract

(EXTRACT OPIUM)

131

Opium tincture

(TINCTURA OPII)

1311

Orthofluorofentanyl

N-(2-Fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl] propanamide

132

Oxymorphone

OXYMORPHONE

14-hydroxydihydromorphinone

(derivate of morphine)

(derivative of morphine)

1321

Ocfentanil

N-(2-Fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide

133

Para-fluorofentanyl

PARA-FLUOROFENTANYL

4'-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide

1331

Parafluorobutyrylfentanyl

N-(4-Fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide

134

Parahexyl

PARAHEXYL

3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol

135

Pethidine synthesis intermediate A

PETHIDINE INTERMEDIATE A

4-cyano-1-methyl-4-phenylpiperidine

136

Pethidine synthesis intermediate B

PETHIDINE INTERMEDIATE B

4-phenylpiperidine-4-carboxylic acid ethyl ester

137

Pethidine synthesis intermediate C

PETHIDINE INTERMEDIATE C

1-methyl-4-phenylpiperidine-4-carboxylic acid

1371

Pentedrone

PENTEDRONE

138

PEPAP

1-phenethyl-4-phenyl-4-piperidinol acetate (ester)

139

Piminodine

PIMINODINE

4-phenyl-1-(3-phenylaminopropyl)piperidine-4-carboxylic acid ethyl ester

140

PMA

p-methoxy-α-methylphenethylamine

141

(removed – 16 April 2014, No. 2235)

142

Properidine

PROPERIDINE

1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester

143

Proheptazine

PROHEPTAZINE

1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane

144

Psilocine, psilotsin

PSILOCINE, PSILOTSIN

3-[2-(dimethylamino)ethyl]indol-4-ol

145

Psilocybine

PSILOCYBINE

3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen phosphate

146

(removed – 16 April 2014, No. 2235)

147

(removed – 16 April 2014, No. 2235)

148

(removed – 16 April 2014, No. 2235)

149

(removed – 16 April 2014, No. 2235)

150

Racemethorphan

RACEMETHORPHAN

(±)-3-methoxy-N-methylmorphinan

151

Racemoramide

RACEMORAMIDE

(±)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine

152

Rolicyclidine

ROLICYCLIDINE (PHP, PCPY)

1-(1-phenylcyclohexyl)pyrrolidine

153

(removed – 16 April 2014, No. 2235)

154

STP, DOM

2,5-dimethoxy-α,4-dimethylphenethylamine

155

Tenamfetamine (MDA)

TENAMFETAMINE (MDA)

α-methyl-3,4-(methylenedioxy)phenethylamine

156

Tenocyclidine

TENOCYCLIDINE (TCP)

1-[1-(2-thienyl)cyclohexyl]piperidine

157

Tetrahydrocannabinols, the following isomers and their stereochemical variants:

tetrahydrocannabinol, the following isomers and their stereochemical variants:

7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol; (9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H- dibenzo[b,d]pyran-1-ol; (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H- dibenzo[b,d]pyran-1-ol; (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H- dibenzo[b,d]pyran-1-ol; 6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol; (6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene3- pentyl-6H-dibenzo[b,d]pyran-1-ol

1571

Tetrahydrofuranylfentanyl

(THF-F)

N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide

158

(deleted – 16.04.2014, No. 2235)

159

TMA

(±)-3,4,5-trimethoxy-α-methylphenethylamine

1591

U-47700

3,4-dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide

1592

UR-144

(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

160

Phenampromide

PHENAMPROMIDE

N-(1-methyl-2-piperidinoethyl)propionanilide

161

Phenomorphan

PHENOMORPHAN

3-hydroxy-N-phenethylmorphinan

162

Phenoperidine

PHENOPERIDINE

1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester

1621

FUB-AMB

(MMB-FUBINACA, AMB-FUBINACA)

FUB-AMB

(MMB-FUBINACA, AMB-FUBINACA)

Methyl(2S)-2-({1-[4-fluorophenyl]methyl-1H-indazole-3-carbonyl }amino)-3-methylbutanoate

1622

Flubromazolam

8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine

163

(deleted – 16.04.2014, No. 2235)

1631

Furanylfentanyl

N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide

164

Furethidine

FURETHIDINE

1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester

165

CP 47,497

5-(1,1-dimethylhexyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol

1651

Cyclopropylfentanyl Cyclopropylfentanyl

N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] cyclopropanecarboxamide

166

(deleted – 16.04.2014, No. 2235)

167

(deleted – 16.04.2014, No. 2235)

168

(deleted – 16.04.2014, No. 2235)

169

JWH-018

Naphthalen-1-yl-(1-pentylindol-3-yl)methanon

170

JWH-073

1-butyl-3-(1-naphthoyl)indole

171

JWH-200

1-[2-(4-morpholino)ethyl]-3-(1-naphthoyl)indole

172

JWH-250

1-pentyl-3-(2-methoxyphenylacetyl)indole

173

JWH-398

1-pentyl-3-(4-chloro-1-naphthoyl)indole

174

(deleted – 16.04.2014, No. 2235)

175

Opium poppy

PAPAVER SOMNIFERUM

176

Poppy straw

POPPY STRAW

all parts(except the seeds) of the opium poppy, after mowing

All parts of the mown opium poppy, except the poppy seeds

177

Concentrate of poppy straw

CONCENTRATE OF POPPY STRAW

the material arising when poppy straw has entered into a process for the concentration of its alkaloids when such material is made available in trade, (“Poppy straw”: all parts (except the seeds) of the opium poppy, after mowing)

(the material arising when poppy straw has entered into a process for the concentration of the alkaloids contained therein, if such material is made available in trade)

178

Extract of poppy straw

EXTRACT OF POPPY STRAW

narcotically active alkaloids obtained from opium poppy straw in any manner, as well as any preparation made from poppy straw by handicraft methods

179

Any kind of tincture and coagulated juice of poppy (opium poppy)

THE COAGULATED JUICE AND TINCTURS OF POPPY STRAW

180

Poppy of all species and the product prepared therefrom which is not opium poppy but contains a narcotic drug indicated in this list

181

Heroin

HEROIN

diacetylmorphine

(derivative of morphine)

182

HU-210

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol

183

JWH-081

4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl) methanone

184

JWH-122

4-methyl-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone

185

JWH-2201

JWH-2201 (AM-2201)

[1-(5-Fluoropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

186

25B-NBOMe

25B-NBOMe (2C-B-NBOMe)

2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

187

25C-NBOMe

25C-NBOMe (2C-C-NBOMe)

2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

188

25I-NBOMe

25I-NBOMe (2C-I-NBOMe)

2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

189

3398-68-3 (PMMA)

para-methoxymethylamphetamine

Law of Georgia of 25 December 2013 No. 1866 – website, 28.12.2013

Law of Georgia of 16 April 2014 No. 2235 – website, 28.04.2014

Law of Georgia of 4 April 2018 No. 2118 – website, 19.04.2018

Law of Georgia of 17 April 2019 No. 4499 – website, 24.04.2019

Law of Georgia of 25 June 2020 No. 6499 – website, 01.07.2020

Law of Georgia of 2 May 2023 No. 2792 – website, 11.05.2023

Law of Georgia of 13 December 2023 No. 3896 – website, 25.12.2023

Notes:

1. The following shall also be classified under List I:

a) isomers of the substances included therein, where the existence of such isomers is possible within the scope of the given specific chemical designation, except where an isomer of any substance is specifically excluded from this list;

b) ethers and esters of the substances included therein, where the existence of such ethers is possible;

c) salts of the isomers and ethers and esters of the substances included therein, where the existence of such salts is possible;

d) dosage forms of the substances included therein, where the existence of such dosage forms is possible;

e) reference standard samples of the substances included therein;

f) mixture.

2. The isomers of levomethorphan and levorphanol, namely dextromethorphan [(+)-3-methyl-N-methylmorphinan] and dextrorphan [(+)-3-hydroxy-N-methylmorphinan], which are specifically excluded from this List, shall not be assigned to List I.

3. (Removed – 16.04.2014, No. 2235).

Law of Georgia of 16 April 2014 No. 2235 – website, 28.04.2014.

Law of Georgia of 16 November 2021 No. 1015 – website, 22.11.2021.

List II

Narcotic drugs restricted for circulation

No.

Name of substance

Chemical name

2 C-B

4-bromo-2,5-dimethoxyphenethylamine

Allylprodine

ALLYLPRODINE

3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine

Alphaprodine

ALPHAPRODINE

α-1,3-dimethyl-4-phenyl-4-propionoxypiperidine

Alfentanil

ALFENTANIL

N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide

Amineptine

AMINEPTINE

7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl) amino]heptanoic acid

Amobarbital

AMOBARBITAL

5-ethyl-5-isopentylbarbituric acid

Amfetamine

AMFETAMINE (amphetamine)

(±)-α-methylphenethylamine

Anileridine

ANILERIDINE

1-p-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester

Acetyldihydrocodeine

ACETYLDIHYDROCODEINE

(derivative of codein)

(derivative of codeine)

Buprenorphine

BUPRENORPHINE

2l-cyclopropyl-7- α -[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14- endo-ethano-6,7,8,14-tetrahydrooripavine

Butalbital

BUTALBITAL

5-allyl-5-isobutylbarbituric acid

Butorphanol

BUTORPHANOL

17-cyclobutylmethyl-morphinan-3,14-diol

121

Gamma-hydroxybutyric acid

GHB

γ-hydroxybutyric acid

Glutethimide

GLUTETHIMIDE

2-ethyl-2-phenylglutarimide

Dexamfetamine

DEXAMFETAMINE (dexamphetamine)

(+)-α-methylphenethylamine

Dextromoramide

DEXTROMORAMIDE

(+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl) butyl]morpholine

(dextro-rotatory isomer of moramide)

Dextropropoxyphene

DEXTROPROPOXYPHENE

α -(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate

(Dextro-rotary isomer of propoxyphene)

(dextro-rotary isomer of propoxyphene)

Diethylthiambutene

DIETHYLTHIAMBUTENE

3-diethylamino-1,1-di-(2’-thienyl)-1-butene

Dimethylthiambutene

DIMETHYLTHIAMBUTENE

3-dimethylamino-1,1-di-(2'-thienyl)-1-butene

Dimenoxadol

DIMENOXADOL

2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate

Dioxaphetyl butyrate

DIOXAPHETYL BUTYRATE

ethyl-4-morpholino-2,2-diphenylbutyrate

Dipipanone

DIPIPANONE

4,4-diphenyl-6-piperidine-3-heptanone

Diphenoxylate

DIPHENOXYLATE

1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester

Difenoxin

DIFENOXIN

1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic acid

Dihydrocodeine

DIHYDROCODEINE

(derivative of morphine)

Dronabinol

DRONABINOL

This international non-proprietary name designates only one stereochemical isomer of delta-9-tetrahydrocannabinol, namely,

(-)-trans-delta-9-tetrahydrocannabinol

This international non-proprietary name refers to only one of the stereochemical variants of delta-9-tetrahydrocannabinol, namely (-)-trans-delta-9-tetrahydrocannabinol

(6aR,10aR)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-1-ol

DROTEBANOL

3,4-dimethoxy-17-methylmorphinan-6β,14-diol

ETHYLMORPHINE

3-ethylmorphine

(derivative of morphine)

ETOXERIDINE

1-[2-(2-hydroxyethoxy)-ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester

ZIPEPROL

α - (α -methoxybenzyl)-4- (β -methoxyphenethyl)-1-piperazineethanol

THEBAINE

(an alkaloid of opium; also found in Papaver bracteatum)

(an alkaloid of opium; it is also contained in the plant Papaver bracteatum)

THEBACON

Acetyldihydrocodeinone (acetylatedenol form of hydrocodone)

CATHINE

CATHINE (+)-norpseudoephedrine

(+)-(S)- α -[(S)-1-aminoethyl]benzyl alcohol

CLONITAZENE

2-(p-chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole

CODEINE

3-methylmorphine

(derivate of morphine, alkaloid contained in opium & poppy straw)

(derivative of morphine; an alkaloid contained in opium and poppy straw)

COCAINE

methyl ester of benzoylecgonine

(an alkaloid found in coca leaves or prepared by synthesis from ecgonine)

(an alkaloid contained in coca leaves or obtained by synthesis from ecgonine)

LEVAMFETAMINE

LEVAMFETAMINE (levamphetamine)

(–)-(R)- α -methylphenethylamine(amphetamine(-)isomer 37 LEVOMETHAMPHETAMINE LEVOMETHAMPHETAMINE (–)-N,α-dimethylphenethylamine 38 LEVORPHANOL LEVORPHANOL (-)-3-hydroxy-N-methylmorphinan 39 METHAQUALONE METHAQUALONE 2-methyl-3-o-tolyl-4(3H)-quinazolinone 40 METHADONE METHADONE 6-dimethylamino-4,4-diphenyl-3-heptanone 41 METHYLPHENIDATE METHYLPHENIDATE methyl α-phenyl-2-piperidine acetate 42 METAMFETAMINE METAMFETAMINE (methamphetamine) (+)-(S)-N,α-dimethylphenethylamine 43 METAMFETAMINE RACEMATE METAMFETAMINE RACEMATE (methamphetamine racemate) (±)-N,α-dimethylphenethylamine 44 MECLOQUALONE MECLOQUALONE 3-(o-chlorophenyl)-2-methyl-4(3H)-quinazolinone 45 MORPHINE MORPHINE the principal alkaloid of opium and of opium poppy (the principal alkaloid of opium or of the opium (soporific) poppy) 46 NALBUPHINE

NALBUPHINE

(–)-17-(cyclobutylmethyl)- 4,5 α -epoxymorphinan- 3,6 α ,14-triol hydrochloride

NICODICODINE

6-nicotinyldihydrocodeine

(derivative of morphine)

NICOCODINE

6-nicotinylcodeine

(derivative of morphine)

NICOMORPHINE

3,6-dinicotinylmorphine

(derivate of morphine)

(derivative of morphine)

NORCODEINE

N-demethylcodeine

(derivative of morphine)

NORMETHADONE

6-dimethylamino-4,4-diphenyl-3-hexanone

Norpipanone

NORPIPANONE

4,4-diphenyl-6-piperidino-3-hexanone

Oripavine

ORIPAVINE

3-O-demethylthebaine

Medicinal opium

OPII MEDICINALIS

Oxycodone

OXYCODONE

14-hydroxydihydrocodeinone

(derivate of morphine)

(derivative of morphine)

Pantopon

PANTOPON

Papaveritum (Omnopon)

PAPAVERITUM (OMNOPON)

Pethidine

PETHIDINE

1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester

Pentazocine

PENTAZOCINE

(2R*,6R*,11R*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3- methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol

Pentobarbital

PENTOBARBITAL

5-ethyl-5-(1-methylbutyl)barbituric acid

Piritramide

PIRITRAMIDE

1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide

Propiram

PROPIRAM

N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide

Racemorphan

RACEMORPHAN

(±)-3-hydroxy-N-methylmorphinan

Remifentanil

REMIFENTANIL

1-(2-methoxycarbonylethyl)-4-(phenylpropionylamino)-piperidine-4-carboxylic acid methyl ester

Secobarbital

SECOBARBITAL

5-allyl-5-(1-methylbutyl)barbituric acid

Sufentanil

SUFENTANIL

N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide

Tilidine

TILIDINE

(±)-ethyl-trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate

Tramadol

TRAMADOL

(1R,2R)-rel-2-[(dimethylamino)methyl]- 1-(3-methoxyphenyl)cyclohexanol

Trimeperidine

TRIMEPERIDINE

1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine

Phenadoxone

PHENADOXONE

6-morpholino-4,4-diphenyl-3-heptanone

Phenazocine

PHENAZOCINE

2'-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan

Fenetylline

FENETYLLINE

7-[2-[(α-methylphenethyl)amino]ethyl]theophylline

Phenmetrazine

PHENMETRAZINE

3-methyl-2-phenylmorpholine

Fentanyl

FENTANYL

7-[2-[(α-methylphenethyl)amino]ethyl]theophylline

Phencyclidine

PHENCYCLIDINE (PCP)

1-(1-phenylcyclohexyl)piperidine

Flunitrazepam

FLUNITRAZEPAM

5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4- benzodiazepin-2-one

Pholcodine

PHOLCODINE

morpholinylethylmorphine

(derivative of morphine)

Cyclobarbital

CYCLOBARBITAL

5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid

Hydrocodone

HYDROCODONE

dihydrocodeinone

(derivative of morphine)

Hydromorphinol

HYDROMORPHINOL

14-hydroxydihydromorphine

(derivative of morphine)

Hydromorphone

HYDROMORPHONE

dihydromorphinone

(derivative of morphine)

Hydroxypethidine

HYDROXYPETHIDINE

4-m-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester

Notes: The following belong to List II:

b) simple and complex ethers of the substances contained therein, if the existence of such ethers is possible;

c) salts of the isomers and of the simple and complex ethers of the substances contained therein, if the existence of such salts is possible;

d) dosage forms of the substances contained therein and of their salts (registered or unregistered in Georgia) under any trade name, if the existence of such dosage forms is possible;

e) preparations of the following narcotic drugs:

e.a) all combined preparations containing acetyldihydrocodeine, dihydrocodeine, codeine, nicodicodine, nicocodeine, norcodeine, pholcodine and ethylmorphine;

Law of Georgia No. 2043 of 5 March 2014 – website, 12.03.2014.

e.b) those combined preparations containing propiram which contain 100 mg and more than 100 mg of propiram per dosage unit, combined with not less than the same quantity of methylcellulose;

e.c) orally administrable combined preparations containing dextropropoxyphene which contain 135 mg and more than 135 mg of dextropropoxyphene per dosage unit, or where in undivided preparations its concentration is 2.5 per cent and more than 2.5 per cent, only on condition that this preparation shall not contain any of the substances provided for by the 1971 United Nations Convention on Psychotropic Substances;

e.d) those combined preparations containing cocaine which contain more than 0.1 per cent of cocaine calculated as cocaine base;

e.e) those combined preparations containing opium or morphine which contain more than 0.2 per cent of morphine calculated as anhydrous morphine base;

e.f) those combined preparations containing diphenoxin which contain 0.5 mg and more than 0.5 mg of diphenoxin and such quantity of atropine sulphate as is equivalent to 5 per cent of the dose of diphenoxin;

e.g) those combined preparations containing diphenoxylate which contain 2.5 mg and more than 2.5 mg of diphenoxylate (calculated as diphenoxylate base) and such quantity of atropine sulphate as is equivalent to 1 per cent of the dose of diphenoxylate;

e.h) Pulvis ipecacuanhae et opii compositus :

e.h.a) 10 per cent opium powder;

e.h.b) 10 per cent ipecacuanha root, well mixed with 80 per cent of any other ingredient in powder form which does not contain any narcotic drug;

e.i) reference standard samples of the substances contained therein;

e.j) all combined preparations containing buprenorphine.

Law of Georgia No. 2561 of 29 July 2014 – website, 06.08.2014.

Law of Georgia No. 1044 of 16 June 2017 – website, 28.06.2017.

List III

Psychotropic substances

No.

Name of substance

Chemical name

Allobarbital

ALLOBARBITAL

5,5-diallylbarbituric acid

Alprazolam

ALPRAZOLAM

8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine

Aminorex

AMINOREX

2-amino-5-phenyl-2-oxazoline

Amfepramone

AMFEPRAMONE (DIETHYLPROPION)

2-(diethylamino)propiophenone

Barbital

BARBITAL

5,5-diethylbarbituric acid

Benzphetamine

BENZFETAMINE (benzphetamine)

N -benzyl-N, α -dimethylphenethylamine

Bromazepam

BROMAZEPAM

7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one

Brotizolam

BROTIZOLAM

2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s- triazolo[4,3-a][1,4]diazepine

Butobarbital

BUTOBARBITAL (BUTOBARBITAL)

5-butyl-5-ethylbarbituricacid

Delorazepam

DELORAZEPAM

7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4- benzodiazepin-2-one

Diazepam

DIAZEPAM

7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin- 2-one

Ethyl Loflazepate

ETHYL LOFLAZEPATE

ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4- benzodiazepine-3-carboxylate

Etilamfetamine

ETILAMFETAMINE

(N-ETHYLAMPHETAMINE)

N -ethyl-α-methylphenethylamine

Ethinamate

ETHINAMATE

1-ethynylcyclohexanolcarbamate

Ethchlorvynol

ETHCHLORVYNOL

1-chloro-3-ethyl-1-penten-4-yn-3-ol

Estazolam

ESTAZOLAM

8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine

161

Ephedrine

EPHEDRINE

([R-(R*,S*)]--[1-(methylamino)ethyl]benzenemethanol 162 Etizolam Etizolam 4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3a][1,4]diazepine 17 Vinylbital VINYLBITAL 5-(1-methylbutyl)-5-vinylbarbituric acid 18 Zolpidem ZOLPIDEM N,N,6-trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide 19 Tianeptine TIANEPTINE (RS)-7-(3-chloro-6-methyl-6,11-dihydrodibenzo [c,f][1,2]thiazepin-11-ylamino) heptanoic acid S,S-dioxide 20 Camazepam CAMAZEPAM 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4- benzodiazepin-2-one dimethylcarbamate (ester) 21 Ketazolam KETAZOLAM 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H- [1,3]oxazino[3,2-d][1,4]benzodiazepin-4,7(6H)-dione 22 Ketamine KETAMINE (RS)-2-(2-Chlorophenyl)-2- (methylamino)cyclohexanone 23 Clobazam CLOBAZAM 7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine- 2,4(3H,5H)-dione

Clonazepam

CLONAZEPAM

5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin- 2-one

Clorazepate

CLORAZEPATE

7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3- carboxylic acid

Clotiazepam

CLOTIAZEPAM

5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H- thieno[2,3-e]-1,4-diazepin-2-one

Cloxazolam

CLOXAZOLAM

10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydro-oxazolo- [3,2-d][1,4]benzodiazepin-6(5H)-one

Lefetamine

LEFETAMINE (SPA)

(–)-N,N-dimethyl-1,2-diphenylethylamine

Loprazolam

LOPRAZOLAM

6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl) methylene]-8- nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one

Lorazepam

LORAZEPAM

7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4- benzodiazepin-2-one

Lormetazepam

LORMETAZEPAM

7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl- 2H-1,4-benzodiazepin-2-one

Mazindol

MAZINDOL

5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol

Medazepam

MEDAZEPAM

7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4- benzodiazepine

MESOCARB

3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine

METHYLPHENOBARBITAL

5-ethyl-1-methyl-5-phenylbarbituric acid

METHYPRYLON

3,3-diethyl-5-methyl-2,4-piperidine-dione

MEPROBAMATE

2-methyl-2-propyl-1,3-propanedioldicarbamate

MEFENOREX

N-(3-chloropropyl)-α-methylphenethylamine

MIDAZOLAM

8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine

40 (removed – 29.07.2014, No. 2561)

NIMETAZEPAM

1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one

NITRAZEPAM

1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one

NORDAZEPAM

7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one

43¹

NOREPHEDRINE

(R*,S*)-µ-(1-aminoethyl)benzenemethanol

OXAZEPAM

7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one

OXAZOLAM

10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one

PEMOLINE

2-amino-5-phenyl-2-oxazolin-4-one

PINAZEPAM

7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepin-2-one

PIPRADROL

1,1-diphenyl-1-(2-piperidyl)methanol

PYROVALERONE

4'-methyl-2-(1-pyrrolidinyl)valerophenone

PRAZEPAM

7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one

PREGABALIN

(S)-3-(aminomethyl)-5-methylhexanoic acid

RELADORM

Cyclobarbital 0.1g + Diazepam 0.001g

SECBUTABARBITAL

5-sec-butyl-5-ethylbarbituric acid

TEMAZEPAM

7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one

TETRAZEPAM

7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one

TRIAZOLAM

8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine

PHENAZEPAM

7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one

PHENDIMETRAZINE

(+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine

FENCAMFAMIN

N-ethyl-3-phenyl-2-norbornanamine

PHENOBARBITAL

5-ethyl-5-phenylbarbituric acid

FENPROPOREX

(±)-3-[(α-methylphenylethyl)amino]propionitrile

PHENTERMINE

α,α-dimethylphenethylamine

62¹

Flualprazolam

8-Chloro-6-(2-fluoro-phenyl)-1-methyl-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepime

FLUDIAZEPAM

7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one

FLURAZEPAM

7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one

64¹

PSEUDOEPHEDRINE

([S-(R*,R*)]--[1-(methylamino)ethyl] benzenemethanol)

CHLORDIAZEPOXIDE

7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4- oxide

Halazepam

HALAZEPAM

7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4- benzodiazepin-2-one

Haloxazolam

HALOXAZOLAM

10-bromo-11b-(o-fluorophenyl)-2,3,7,11b- tetrahydrooxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-one

Gabapentin

2-[1-(aminomethyl)cyclohexyl]acetic acid

Baclofen Baclofen

4-amino-3-(4-chlorophenyl)butanoic acid

Trihexyphenidyl (Cyclodol)

1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol

Notes: The following belong to List III:

a) medicinal forms of the substances included therein and of their salts (registered or unregistered in Georgia) under any trade name, if the existence of such medicinal forms is possible;

b) reference standard samples of the substances included therein;

c combined preparations containing ephedrine, norephedrine and pseudoephedrine.

Law of Georgia of 5 March 2014 No. 2043 – website, 12.03.2014

Law of Georgia of 29 July 2014 No. 2561 – website, 06.08.2014

Law of Georgia of 16 November 2021 No. 1015 – website, 22.11.2021

Law of Georgia of 16 April 2025 No. 505 – website, 17.04.2025

List IV

Precursors

Table No. 1

No.

Name of the substance

Chemical name

1-phenyl-2-propanone

1-PHENYL-2-PROPANONE

(1-phenyl-2-propanone)

3,4-MDP-2-P methyl glycidate

2-oxiranecarboxylic acid, 3-(1,3- benzodioxol-5-yl)-2-methyl-, methyl ester]

3,4-MDP-2-P methyl glycidic acid

2-oxiranecarboxylic acid,

3-(1,3-benzodioxol-5-yl)-2-methyl-

3,4-methylenedioxyphenyl-2-propanone

3,4-METHYLENEDIOXYPHENYL-2-PROPANONE

(2-propanone,1-[3,4(methylenedioxy)phenyl]-)

4-anilino-N-phenethylpiperidine (ANPP)

4-Anilino-N-phenethylpiperidine (ANPP)

(N-phenyl-1-(2-phenylethyl)piperidin-4-amine)

HS code: 2933.39 CAS number: 21409-26-7

N-acetylanthranilic acid

N-ACETYLANTHRANILIC ACID

(benzoic acid, 2-(acetylamino)-)

alpha-phenylacetoacetonitrile

alpha-Phenylacetoacetonitrile (APAAN)

3-oxo-2-phenylbutanenitrile

N-phenethyl-4-piperidone (NPP)

N -Phenethyl-4-piperidone (NPP)

(1-(2-phenylethyl)-piperidin-4-one)

HS code: 2933.39 CAS number: 39742-60-4

alpha-phenylacetoacetamide (APAA)

alpha-Phenylacetoacetamide

(APAA)

benzeneacetamide, α-acetyl-

N-phenyl-4-piperidinamine (4-AP)

N-Phenyl-4-piperidinamine (4-AP)

(4-Piperidinamine, N-phenyl-)

HS code: 2933.39

CAS number: 23056-29-3

Ergometrine

ERGOMETRINE

(ergoline-8-carboxamide,9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methyl-,[8ß(S)])

Ergotamine

ERGOTAMINE

(ergotaman-3',6',18'-trione,12'-hydroxy-2'-methyl-5'-(phenylmethyl)-,(5))

(removed – 05.03.2014, No. 2043)

Isosafrole

ISOSAFROLE

(1,3-benzodioxole,5-(1-propenyl)-)

Potassium permanganate

POTASSIUM PERMANGANATE

(permanganic acid (HMnO4), potassium salt)

Methyl alpha-phenylacetoacetate (MAPA)

Methyl 3-oxo-2-phenylbutanoate

(removed – 05.03.2014, No. 2043)

Piperonal

PIPERONAL

(1,3-benzodioxole-5-carboxaldehyde)

Safrole

SAFROLE

(1,3-benzodioxole,5-(2-propenyl)-)

111

tert-Butyl 4-(phenylamino)piperidine-1-carboxylate

(1-Boc-4-AP)

tert-Butyl 4-(phenylamino)piperidine-1- carboxylate

(1-boc-4-AP)

(4-(phenylamino)-1-piperidinecarboxylic acid, 1,1 dimethylethyl ester)

HS code: 2933.34

CAS number: 125541-22-2

(removed – 05.03.2014, No. 2043)

Phenylacetic acid

PHENYLACETIC ACID

(benzeneacetic acid)

Acetic anhydride

ACETIC ANHYDRIDE

(acetic oxide)

Law of Georgia of 5 March 2014 No. 2043 – website, 12.03.2014

Law of Georgia of 10 December 2015 No. 4588 – website, 16.12.2015

Law of Georgia of 17 April 2019 No. 4499 – website, 24.04.2019

Law of Georgia of 25 June 2020 No. 6499 – website, 01.07.2020

Law of Georgia of 16 November 2021 No. 1015 – website, 22.11.2021

Law of Georgia of 13 December 2023 No. 3896 – website, 25.12.2023

Notes: The following belong to Table No. 1 of List IV:

a) salts of the substances included therein, if the existence of such salts is possible;

b) medicinal forms of the substances included therein and of their salts (registered or unregistered in Georgia) under any trade name, if the existence of such medicinal forms is possible;

c) reference standard samples of the substances included therein.

Table No. 2

No.

Name of substance

Chemical name

Anthranilic acid

ANTHRANILIC ACID

(2-aminobenzoic acid)

Acetone

ACETONE

(2-propanone)

Concentrated sulphuric acid

SULPHURIC ACID

(sulfuric acid)

Ethyl ether

ETHYL ETHER

(1,1'-oxybis[ethane])

Concentrated hydrochloric acid

HYDROCHLORIC ACID

(hydrochloric acid)

Methyl ethyl ketone

METHYL ETHYL KETONE

(2-butanone)

Piperidine

PIPERIDINE

(piperidine)

Toluene

TOLUENE

(benzene, methyl-)

Notes: The following belong to Table No. 2 of List IV:

a) salts of the substances included therein (except salts of sulphuric acid and hydrochloric acid), if the existence of such salts is possible;

b) reference standard samples of the substances included therein.

Annex No. 2

Law of Georgia of 24 July 2013 No. 845 – website, 13.08.2013

Law of Georgia of 26 July 2017 No. 1219 – website, 28.07.2017

Law of Georgia of 5 March 2021 No. 324 – website, 09.03.2021

Law of Georgia of 30 May 2024 No. 4236 – website, 13.06.2024

Law of Georgia of 16 April 2025 No. 505 – website, 17.04.2025

List of small, large and especially large quantities of narcotic drugs and psychotropic substances withdrawn from illegal possession or circulation

No.

Name of plant, substance and preparation

Quantity (in grams)

small

large

especially large

Narcotic drugs

Allylprodine

Alphamethadol

Alpha-methylthiofentanyl

Alpha-methyl-4-methylthiophenethylamine

Alpha-methylfentanyl

Alphameprodine

Alphaprodine

Alphacetylmethadol

Alfentanil

Amineptine

0,1

Amobarbital (barbamyl)

Amphetamine

0,005

0,1

Anileridine

Acetyl-alpha-methylfentanyl

Acetyldihydrocodeine

Acetylmethadol

Acetorphine

Bezitramide

Benzethidine

Benzylmorphine

Betamethadol

Betameprodine

Betaprodine

Betacetylmethadol

Beta-hydroxy-3-methylfentanyl

Beta-hydroxyfentanyl

Brolamphetamine (DOB)

2C-B (4-bromo-2,5-dimethoxyphenethylamine)

Buprenorphine

0,0012

0,012

0,03

Butalbital

0,005

0,05

0,5

Butorphanol

0,02

0,2

311

Gamma-hydroxybutyric acid

GHB

Glutethimide (noxiron)

100

Desomorphine

0,001

0,01

DET

Dexamphetamine

Dextromoramide

Dextropropoxyphene

Diampromide

Diethylthiambutene

Dimethylthiambutene

Dimenoxadol

Dimepheptanol

Dioxaphetyl butyrate

Dipipanone

Diphenoxylate

Diphenoxine

Dihydroetorphine

Dihydrocodeine

Dihydromorphine

DMA (2,5-dimethoxyamphetamine)

DMT (dimethyltryptamine)

0,005

0,05

DMHP (dimethylheptylpyran)

DOET (2,5-dimethoxy-4-ethylamphetamine)

Dronabinol

0,002

0,02

0,2

Drotebanol

N-ethyl MDA (base and salts)

Ethylmethylthiambutene

Ethylmorphine

0,6

Ecgonine

0,02

Etaminal sodium

0,6

Eticyclidine

Etonitazene

Etorphine

Etoxeridine

Etryptamine

Zipeprol

0,5

Thebaine

Thebacon

Thiofentanyl

Isomethadone

Cathine (norpseudoephedrine)

Cathinone

Cannabis plant

155

750

Cannabis extract and tincture

Cannabis oil

Cannabis resin

0,05

0,5

Ketobemidone

Clonitazene

Codeine (base and salts)

0,2

Codeine-N-oxide

Codoxime

Cocaine (base and salts)

0,06

0,6

d-Cocaine

0,06

0,6

Coca leaf (except leaves from which ecgonine, cocaine and any other ecgonine alkaloids have been completely removed)

− dried

− fresh

125

250

Levoamphetamine

Levomethorphan

Levomethamphetamine

Levomoramide

Levorphanol

Levophenacylmorphan

Lysergic acid, its derivatives and preparations, including lysergide

0,00002

0,0002

0,001

Marijuana

− dried

− raw

140

250

500

MDMA (3,4-methylenedioxymethamphetamine)

0,05

0,5

Methadone (base and salts)

0,005

0,2

D - Methadone

L - Methadone

Intermediate product of methadone synthesis

Methaqualone (base and salts)

4-Methylaminorex

100

Methyldesorphine

101

Methyldihydromorphine

102

3-Methylthiofentanyl

103

Methylphenidate

104

3-Methylfentanyl

105

Methcathinone (ephedrone)

0,005

0,1

106

Mecloqualone

107

Mescaline

0,0006

108

Metazocine

109

Methamphetamine (base and salts, regardless of the presence of accompanying substances)

0,005

0,1

110

Methamphetamine racemate

111

Metopon

112

Myrophine

113

MMDA (5-methoxy-3,4-methylenedioxyamphetamine)

114

Intermediate product of moramide

115

Morpheridine

116

Morphine (base and salts)

0,04

0,4

117

Morphine methobromide

0,04

0,4

118

Morphine-N-oxide

119

MPPP

120

Nicodicodine

121

Nalbuphine

0,2

122

Nicocodine

123

Nicomorphine

124

Noracymethadol

125

Norcodeine

126

Norlevorphanol

127

Normethadone

128

Normorphine

129

Norpipanone

130

Papaveritum, Pantopon, Omnopon, Oripavine

0,04

0,4

131

Opium, Amphion

0,2

132

Extraction opium

0,1

133

Medicinal opium

0,2

134

Opium extract

0,1

135

Opium tincture

0,3

136

Oxycodone

137

Oxymorphone

138

Para-fluorofentanyl

139

Parahexyl

140

Pethidine

0,04

0,4

141

Intermediate products of pethidine synthesis A, B, C

142

Pentazocine

0,1

143

Pentobarbital

0,005

0,05

0,5

144

PEPAP

145

Piminodine

146

Piritramide

147

PMA (base and salts)

148

Properidine

149

Propiram

150

Proheptazine

151

Psilocybine

0,002

152

Psilocine, psilotsin

0,002

153

Any species of mushroom containing psilocybine or psilocine

0,5

154

Racemethorphan

155

Racemoramide

156

Racemorphan

157

Remifentanil

158

Rolicyclidine (base and salts)

159

Secobarbital

0,005

0,05

0,5

160

STP, DOM (base and salts)

161

Sufentanil

162

Tenamphetamine (base and salts)

163

Tenocyclidine (base and salts)

164

Tetrahydrocannabinols (all isomers and their stereochemical variants)

0,05

0,5

165

Tilidine

0,01

0,1

166

Tramadol

800

167

TMA

168

Trimeperidine (promedol)

0,08

0,8

169

Phenadoxone

170

Phenazocine

171

Phenampromide

172

Phenetillin

173

Phenmetrazine

174

Phenomorphan

175

Phenoperidine

176

Fentanyl

0.0005

0.005

0.05

177

Phencyclidine

178

Flunitrazepam

0.1

179

Pholcodine

0.02

0.2

180

Furethidine

181

Opium poppy

− dried

− raw

100

500

1000

182

Poppy straw

500

183

Concentrate obtained from poppy straw (calculated as opium)

0.2

184

Poppy straw extract

0.1

185

Any kind of infusion and latex of the poppy (opium poppy)

186

Any species of poppy which is not the opium poppy but contains a narcotic drug

1000

5000

25000

187

Product prepared from any species of poppy which is not the opium poppy but contains a narcotic drug

1.5

150

188

Cyclobarbital (Cicorapiiao)

200

189

Heroin

0.005

0.2

0.5

190

Hydrocodone

0.2

191

Hydromorphinol

192

Hydromorphone

193

N-hydroxy MDA, n-hydroxy-methylenedioxyamphetamine

194

Hydroxypethidine

195

JWH-018

0.05

0.5

196

JWH-398

0.05

0.5

197

JWH-073

0.05

0.5

198

JWH-200

0.05

0.5

199

HU-210

0.05

0.5

200

CP-47, 497

0.05

0.5

201

JWH-250

0.05

0.5

202

JWH-081

0.05

0.5

203

JWH-122

0.05

0.5

204

4,4’-DMAR, 4,4’Dimethylaminorex

205

alpha-PVP

α-PVP

0.001

0.2

206

AH-7921

207

Acetylfentanyl

208

Benzylpiperazine

N-BENZYLPIPERAZINE (Benzylpiperazine, BZP)

0.02

0.2

209

MDPV

MDPV (3,4-Methylenedioxypyrovalerone)

0.005

0.1

210

Methylone

METHYLONE (Beta-keto-MDMA)

211

Methoxetamine

METHOXETAMINE (MXE)

212

Mephedrone

MEPHEDRONE (4-methylmethcathinone)

0.01

0.1

213

MT-45

214

JWH-2201

JWH-2201 (AM-2201)

215

25B-NBOMe

25B-NBOMe (2C-B-NBOMe)

216

25C-NBOMe

25C-NBOMe (2C-C-NBOMe)

217

25I-NBOMe

25I-NBOMe (2C-I-NBOMe)

218

3398-68-3 (PMMA)

219

4-Methylethcathinone

4-METHYLETHCATHINONE

220

5F-APINACA

221

Butyrfentanyl

BUTYRFENTANYL

222

Ethylone

ETHYLONE

223

Ethylphenidate

ETHYLPHENIDATE

224

XLR-11

225

MDMB-CHMICA

226

Methiopropamine

METHIOPROPAMINE

227

Pentedrone

PENTEDRONE

228

U-47700

229

Parafluorobutyrylfentanyl

230

Orthofluorofentanyl

231

Cyclopropylfentanyl

232

Methoxyacetylfentanyl

233

ADB-FUBINACA

234

FUB-AMB (MMB-FUBINACA, AMB-FUBINACA)

235

CUMYL-4CN-BINACA

236

ADB-CHMINACA (MAB-CHMINACA)

237

N-ETHYLNORPENTYLONE (Ephylone)

238

4-Fluoroamphetamine

4-Fluoroamphetamine (4-FA)

239

5F-PB-22

240

UR-144

241

AB-PINACA

0.001

0.01

242

5F-MDMB-PINACA

5F-MDMB-PINACA (5F-ADB)

243

AB-CHMINACA

244

Tetrahydrofuranylfentanyl

Tetrahydrofuranylfentanyl (THF-F)

245

4-Fluoroisobutyrfentanyl

4-Fluoroisobutyrfentanyl (4-FIBF, pFIBF)

246

Acryloylfentanyl (Acrylfentanyl)

247

Furanylfentanyl

248

Ocfentanil

249

Carfentanil

250

4-CMC (clephedrone)

4-CMC (4-chloromethcathinone; clephedrone)

251

4F-MDMB-BINACA

252

5F-AMB-PINACA

(5F-AMB, 5F-MMB-PINACA)

253

5F-MDMB-PICA

(5F-MDMB-2201)

254

N-ethylhexedrone

255

AB-FUBINACA

256

alpha-PHP

257

DOC

258

VALERYLFENTANYL

259

CROTONYLFENTANYL

260

Isotonitazene

261

CUMYL-PEGACLONE

262

MDMB-4en-PINACA

263

3-Methoxyphencyclidine

264

Diphenidine

265

Clonazolam

266

Diclazepam

267

Flubromazolam

268

BRORPHINE

269

METONITAZENE

270

Eutylone

271

Norfentanyl

Psychotropic

substances

Allobarbital

150

1500

Alprazolam

0.25

2.5

Aminorex

0.1

Amfepramone

1.5

150

Barbital

150

1500

Benzfetamine

0.1

Bromazepam

100

Brotizolam

2.5

250

Butobarbital

140

(removed – 29 July 2014, No. 2561)

Delorazepam

0.25

2.5

Diazepam

0.25

2.5

Ethylamphetamine

0.1

Ethyl loflazepate

0.25

2.5

Ethinamate

100

1000

Ethchlorvynol

100

1000

Estazolam

0.1

171

Ephedrine

0.15

1.5

172

Etizolam

Vinylbital

150

1500

Zolpidem

0.25

2.5

Tianeptine

0.125

1.25

12.5

Camazepam

0.25

2.5

Ketazolam

0.25

2.5

Ketamine

0.1

Clobazam

0.5

Clonazepam

0.05

0.5

Clorazepate

0.25

2.5

Clotiazepam

0.25

2.5

Cloxazolam

0.25

2.5

Lefetamine

0.1

Loprazolam

0.25

2.5

Lorazepam

0.125

1.25

12.5

Lormetazepam

0.25

2.5

Mazindol

0.02

0.2

Medazepam

0.5

Mezocarb (Sidnocarb)

0.25

2.5

Methylphenobarbital

150

1500

Methyprylon

0.1

Meprobamate

300

Mephenorex

100

1000

Midazolam

0.75

7.5

Nimetazepam

0.25

2.5

Nitrazepam (Radedorm)

0.15

1.5

Nordazepam

0.25

2.5

431

Norephedrine

0.15

1.5

Oxazepam

0.25

2.5

Oxazolam

0.25

2.5

Pemoline

0.25

2.5

Pinazepam

0.25

2.5

Pipradrol

0.1

Pyrovalerone

0.1

Prazepam

0.25

2.5

Pregabalin

0.6

6.0

Reladorm

Secbutabarbital

140

Temazepam

0.25

2.5

Tetrazepam

2.5

250

Triazolam

0.0125

0.125

1.25

Phenazepam

0.25

2.5

Phendimetrazine

0.25

2.5

Fencamfamine

0.25

2.5

Phenobarbital

250

500

Fenproporex

0.25

2.5

Phentermine

0.1

621

Flualprazolam

Fludiazepam

0.25

2.5

Flurazepam

0.25

2.5

641

Pseudoephedrine

0.3

Chlordiazepoxide

0.25

2.5

25.0

Halazepam

0.25

2.5

Haloxazolam

0.25

2.5

Baclofen

0.01

0.1

0.5

Gabapentin

0.3

Trihexyphenidyl

(Cyclodol)

0.002

0.2

Law of Georgia No. 1866 of 25 December 2013 – website, 28.12.2013.

Law of Georgia No. 2043 of 5 March 2014 – website, 12.03.2014.

Law of Georgia No. 2235 of 16 April 2014 – website, 28.04.2014.

Law of Georgia No. 2561 of 29 July 2014 – website, 06.08.2014.

Law of Georgia No. 2118 of 4 April 2018 – website, 19.04.2018.

Law of Georgia No. 4499 of 17 April 2019 – website, 24.04.2019.

Law of Georgia No. 6499 of 25 June 2020 – website, 01.07.2020.

Law of Georgia No. 1015 of 16 November 2021 – website, 22.11.2021.

Law of Georgia No. 2792 of 2 May 2023 – website, 11.05.2023.

Law of Georgia No. 3896 of 13 December 2023 – website, 25.12.2023.

Notes:

1. The quantities shown in the 3rd, 4th and 5th vertical columns of the table of this list shall be determined as follows:

a) up to the quantity indicated in the 3rd vertical column (inclusive of the indicated quantity) shall be considered a small quantity;

b) more than the quantity indicated in the 3rd vertical column, up to the quantity indicated in the 4th vertical column (inclusive of the indicated quantity) shall be considered the initial quantity for criminal liability;

c) more than the quantity indicated in the 4th vertical column, up to the quantity indicated in the 5th vertical column (inclusive of the indicated quantity) shall be considered a large quantity;

d) more than the quantity indicated in the 5th vertical column shall be considered an especially large quantity.

2. If no quantity is determined in the 3rd vertical column, then:

a) up to the quantity indicated in the 4th vertical column (inclusive of the indicated quantity) shall be considered a large quantity;

b) more than the quantity indicated in the 5th vertical column shall be considered an especially large quantity.

3. The quantity of the psychotropic substance – reladorm – is not defined, since it is a combined preparation.

4. The quantities of narcotic drugs are given and determined without their fillers (flour, sugar, starch, a medicinal product and others).

5. The list of psychotropic substances provided for by this list includes only pure substances and not their medicinal forms, except for the medicinal forms of the psychotropic substances – tianeptine, pregabalin and ketamine.

5¹. Until the quantity of the psychotropic substance – etizolam, flualprazolam – is determined, any quantity thereof shall be considered the threshold quantity for criminal liability.

6. (Removed – 16.04.2014, No. 2235).

7. For the purposes of Article 260³ of the Criminal Code of Georgia, the unlawful sale of the psychotropic substances – gabapentin, baclofen and trihexyphenidyl (cyclodol) – both as pure substances and as medicinal forms, gives rise to the imposition of criminal liability.

8. If the product of the narcotic drug – the cannabis plant – provided for by column 73 of the list "Narcotic drugs" defined by the table of this Annex has an additive, an admixture and/or signs of extraction, its quantity shall be determined according to the content of the narcotic drug – tetrahydrocannabinol – provided for by column 164 of the same list.

Law of Georgia of 25 December 2013 No. 1866 – website, 28.12.2013.

Law of Georgia of 16 April 2014 No. 2235 – website, 28.04.2014.

Law of Georgia of 16 November 2021 No. 1015 – website, 22.11.2021.

Law of Georgia of 16 April 2025 No. 505 – website, 17.04.2025.

Law of Georgia of 2 July 2025 No. 928 – website, 03.07.2025.